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ABSTRACT 
Background: Nearly a million people die of malaria each year, the majority are children in rural 
African settings. These deaths could be reduced if children had prompt access to artemisinin-based 
combination therapy (ACTs), demonstrated adherence to treatment and to referral advice for severe 
malaria. However, health systems are weak to deliver the interventions. Although many African 
countries, including Tanzania, changed malaria treatment policy to ACTs in the last decade, few 
children reportedly get prompt access to ACTs.  
Main aim: To determine factors influencing prompt access to effective antimalarials; adherence to 
treatment schedules and to referral advice among children under five, in rural settings.  
Methods: Community-based studies were conducted in rural villages in Kilosa (I,II) and Mtwara 
rural (II,IV) districts, in Tanzania. Study I and II were prospective designed while study III and IV 
were nested in a community-based rectal-artesunate deployment intervention study. In study I, a 
total of 1,235 children from 12 randomly selected villages were followed up for six months. 
Caretakers of children reported to have fever were interviewed at home about the type and source 
of treatment using a questionnaire. In study II, all children (3918) in five selected villages were 
followed-up for 12 months, to determine adherence to treatment when they had malaria, diagnosed 
using Rapid Diagnostic Test (RDT) and treated with artemether-lumefantrine (ALu). In study III, 
587 children who received pre-referral rectal artesunate during the deployment study were traced 
home and caretakers interviewed on a number of factors likely to influence adherence to referral 
advice, using a questionnaire. Study IV was qualitative, 12 focus group discussions were 
conducted in three purposively selected villages to explore reasons for non-adherence to referral 
advice.  
Results: Only one-third (37.6%) of febrile children had prompt access to ALu, the recommended 
ACTs in Tanzania, mainland (I). Lack of prompt access was mostly (>80 percent) attributed to 
receiving non-recommended drugs. Less than half of the febrile children were taken to government 
facilities, where they were 17-times more likely to have prompt access compared to those who 
went elsewhere. Less than 10% (41/607) of febrile children had access to ALu (I) from faith-based 
organisation facilities and accredited drug dispensing outlets, despite having subsidized ALu. 
Reported adherence to treatment schedules was high (>80 percent) and non-adherence was 
attributed mainly to untimely dosing, rather than taking a fewer number of doses (II). While social 
economic status influenced prompt access to ALu and adherence to treatment, basic education did 
not (I, II). Caretakers of children with altered consciousness and convulsion were almost 4-times 
more likely to adhere to referral advice than those whose children had less severe symptoms (III). 
They seemed to weigh child condition against obstacles to accessing care at health facilities, if the 
condition was less severe prior to or improved after rectal artesunate dose, caretakers were likely to 
be deterred from adhering to referral advice (IV). Detailed understanding of provider’s advice was 
likely to lead to adherence to the treatment schedule (II) and to referral advice (III, IV).  
Conclusion: This thesis has shown that once a child had access to ALu, caretakers were likely to 
adhere to treatment schedule; and to referral advice, if child had severe symptoms or not improved 
after pre-referral treatment. More efforts should therefore be directed towards increasing access to 
ALu by strengthening the public health sector to reach rural remote areas. A wide coverage in 
prompt access to ALu will also reduce the need for the rectal artesunate strategy 
. 
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DEFINITIONS 
 
Access – is the degree of fit between the needs and means of patients (users) and the 
existing services (providers) along the five dimensions of availability, accessibility, 
affordability, adequacy and acceptability, as defined below (Ricketts and Goldsmith, 
2005). 
 
• Availability: The extent to which the existing health services and goods meet 
clients’ needs. 
 
• Accessibility: The extent to which the location of supply is in line with the 
location of clients. 
 
• Affordability: The extent to which the prices of services fit the clients’ income 
and ability to pay. 
 
• Adequacy: The extent to which the organisation of health care meets the clients’ 
expectations. 
 
• Acceptability: The extent to which the characteristics of providers match with 
those of the clients 
 
Adherence to treatment schedule –Administration of ALu according to the 
recommended schedule in the national treatment guidelines (MoH&SW, 2006). In this 
thesis, the caretaker’s report was used as the criteria for adherence to treatment as follows: 
administration of two doses daily for three days or, if the first dose is started in the evening 
or night; one dose on the first day, two doses daily for two days and one dose on the last 
day. 
 
Adherence to referral advice – when a child is taken by the caretaker to a health facility 
after pre-referral treatment with rectal artesunate suppositories by a community drug 
dispenser  
 
Artemisinin-based combination therapy (ACT) is the simultaneous use of two or more 
blood schizontocidal drugs with independent modes of action and thus unrelated 
biochemical targets in the parasite (WHO, 2010a). 
 
Community effectiveness (CE)- the use of health care, diagnostic history-taking, 
diagnostic clinical examination, drug choice, drug treatment, drug-buying and drug-taking 
compliance (Krause and Sauerborn, 2000).  
 
Drug resistance -  is the ability of the parasite to survive or multiply despite the 
administration and absorption of medicine in doses equal or higher than those normally 
recommended within the tolerance of the subject (Bruce-Chwatt, 1986). The drug or active 
metabolite must be able to gain access to the parasite for the normal duration necessary for 
it to act.  
 
  
Health systems is defined to include all actors, organisations, institutions, resources and 
the various activities whose primary purpose is to promote, restore, maintain and improve 
health (WHO, 2000). Health systems comprise of public, private formal and informal 
actors that include traditional medicine. The functions of health systems include: 
governance/stewardship, service provision, resource generation and financing 
 
Malaria control: reducing the malaria disease burden to a level at which it is no longer 
a public health problem (WHO, 2009). 
 
Malaria elimination: the interruption of local mosquito-borne malaria transmission; 
reduction to zero of the incidence of infection caused by human malaria parasites in a 
defined geographical area as a result of deliberate efforts; continued measures to prevent 
re-establishment of transmission are required (WHO, 2009). 
 
Malaria eradication: permanent reduction to zero of the worldwide incidence of 
infection caused by a specific agent; applies to a particular malaria parasite species. 
Intervention measures are no longer needed once eradication has been achieved  (WHO, 
2009). 
 
Off-schedule doses (or untimely doses) – doses administered outside the time range 
stated in the definition of adherence to treatment schedule, see above.  
 
Private sector -  includes formal private for profit and private-not for profit (PNFP) and 
the informal private sector which includes drug vendors and ordinary shopkeepers who 
sell general merchandize including as rice and sugar (World-Bank, 2010).  
 
Prompt access to effective treatment – Ability to access appropriate antimalarial 
treatment within 24 hours of onset of fever (WHO, 2009). In this thesis, artemether-
lumefantrine (ALu), the recommended first line drug for treatment of uncomplicated 
malaria in Tanzania, was regarded as the appropriate antimalarial and prompt access was 
defined as taking ALu on the same or next day after onset of fever (Rutebemberwa et al., 
2009a).   
 
Uncomplicated malaria – Presumptive diagnosis was used in study I based on the WHO 
guidelines for the treatment of  malaria of 2006 (WHO, 2006), whereby, in settings where 
the risk of malaria is high, clinical diagnosis was recommended to be based on a history of 
fever in the previous 24 hours. In study II uncomplicated malaria was defined as patients 
with positive RDT results based on the current WHO guideline  (WHO, 2009) which 
recommends parasitological confirmation of all malaria cases prior to treatment. 
 
Universal coverage – 100% of patients receive locally appropriate case management 
interventions. Coverage is defined as follows:  
• Diagnosis: prompt parasitological diagnosis by microscopy or rapid diagnostic tests 
(RDTs) 
• Treatment: treatment with effective drugs within 24 hours after the first symptoms 
appear (Roll-Back-Malaria-Partnership, 2008)
  
PREFACE 
 
My journey to the topic of this thesis started with inspirational words from the late, 
Mwalimu (teacher) Julius Kambarage Nyerere, the First President of Tanzania - I quote: 
 
“Those who receive this privilege, therefore have a duty to repay the sacrifice that others 
have made. They are like the man who has been given all the food available in a starving 
village in order that he might have strength to bring supplies back from a distant place. If 
he takes this food and he does not bring help to his brothers, he is a traitor. Similarly if 
any of the young men and women who are given education by the people of the republic 
adopt an attitude of superiority, or fail to use their knowledge to help the development of 
this country, then they are betraying our nation”  
 
The statement intrigued me for the first time during my secondary school days when I was 
forced to read it to my fellow students, in the assembly hall. It was then that I committed 
myself to repay my fellow citizens once I got the opportunity. 
 
After training in medicine I had the opportunity to work as a medical officer practitioner in 
referral and district hospitals. The sight of so many children dying of anaemia and cerebral 
malaria made me realise that I could not help the children in the clinic or in the wards. It 
was then that I decided to enter public health with the intention of treating more of them 
before they became sick.   
 
The first challenge to meet in public health was the astounding data on measles mortality 
which left me wondering ‘why should so many children die from measles when a potent 
vaccine is available?’ I took the opportunity of my Masters course to study measles 
vaccine effectiveness under field conditions 
 
After graduating from the Masters course my journey took me to the Ministry of Health, 
where I had the opportunity to address some of the challenges and at the same time 
experience a number of challenges that partly explained what I found in the field. So when 
the next opportunity came I wanted to dwell further on the barriers to delivery of health 
care services so that I could gather more evidence to some of the experiences I already had 
and document them for sharing with others in the quest for a collective solution. This time, 
high measles mortality was history, thanks to high measles vaccination coverage rates, so I 
chose to study the health system given the fact that nearly half of patients attending out-
patient services and one-third of deaths among children admitted in hospitals were due to 
malaria. I was perturbed by the same question ‘why should so many children die from 
malaria when an efficacious drug was available?’  
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1 INTRODUCTION 
1.1 GLOBAL HEALTH AND POVERTY 
About 1.4 billion of the world population lives below the poverty line of 1.25 USD a 
day and the income gap is widening (World-Bank, 2008). While the richest 20% were 
30-times richer than the poorest in 1960, the disparity widened to 74-times in 1994 
(UNDP, 2008). The rural populations account for one-quarter of the poor in the world 
(UNDP, 2008). As a result, one-seventh does not have access to health care services.  
Poverty, disease and ignorance form a vicious cycle. Although it is possible for less 
wealthy countries to have better health and vice versa (Lindstrand et al., 2006), 
countries with higher economic status are generally healthier (Debas, 2010). During the 
turn of this century, for the first time, the health of the poor was recognised to be of 
global concern (Debas, 2010). This led to the Millennium Summit developing the 
Millennium Development Goals (MDGs) with MDGs four, five and six being directly 
related to health of specific populations. This was upon the realisation that achieving 
the MDGs was important for world economic stability, human rights and equity. 
 
MDG 6 aims at halting and reversing the incidence of three major diseases, HIV/AIDS, 
TB, Malaria and other infectious diseases by 2015. Approximately, 8.8 million children 
die each year before the age of 5 years, half of them during the first month of life 
(UNICEF, 2010). Of these, about 4 million are due to malaria, diarrhoea and 
pneumonia (UNICEF, 2010). 
 
Through the implementation of a poverty reduction strategy a decline in poverty level 
of about 60% has been reported with China contributing to the highest decline (70%) 
compared to other poor countries including Africa where the decline was lowest (10%) 
(World-Bank, 2008).  
 
1.2 MALARIA MORBIDITY AND MORTALITY AND CONTROL 
Approximately, 3.3 billion people in the world were at risk of contracting malaria in 
2008 resulting in an estimated 243 million cases and 863,000 deaths (WHO, 2009). 
About 90% of the deaths occurred in Africa and 85% were children under five years. 
The majority of malaria deaths were due to cerebral malaria and anaemia (Snow and 
Guerra, 2005), Plasmodium falciparum species was the cause of deaths and Anopheles 
gambiae, the most efficient vector, commonly found in Africa. 
 
The life cycle of Plasmodium falciparum starts with a bite from an infected female 
Anopheline mosquito on a human being releasing sporozoites from the salivary glands  
(Figure 1) (WHO-Website, 2010). Sporozoites enter the bloodstream and invade liver 
cells (liver stage) and undergo asexual multiplication to form merozoites. Hepatocytes 
burst to release individual merozoites that invade red blood cells (erythrocytic stage) 
where merozoites multiply to form a schizont. Schizonts rupture to release merozoites 
that invade more erythrocytes and some differentiate into male and female gametocytes 
which are taken from the blood stream when a female anopheles mosquito bites a 
human being. In the mosquito midgut, the male gametocyte undergoes nuclear division 
to produce flagellated microgametes which then fertilize the female macrogamete to 
form ookinete. Ookinete implants on the outer side of the mosquito gut wall as an 
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oocyst, later ruptures to release sporozoites that migrate to the mosquito salivary gland 
ready to be injected into a human being. 
             
Figure 1: The life cycle of Plasmodium falciparum 
 
 
  
  
 
 
 
Source:http://www.searo.who.int/en/Section10/Section21/Section340_4269.htm 
 
 
1.3 GLOBAL COMMITMENT TO CONTROL AND ELIMINATE MALARIA 
DEATHS 
Hippocrates was the first scientist to describe malaria associated  with stagnant waters, 
leading to the first control intervention through the drainage of stagnant water (Malaria-
Website, 2010). The first treatment of malaria started about 2,000 years ago by the 
Chinese using the bark of the Cinchona tree (Hsu, 2006 ). It was not until 1889 when 
the agent causing malaria was discovered by Alphonse Laveran in 1889, that the scene 
for malaria diagnosis was set. In 1897, Ronald Ross discovered the association of the 
parasite with the vector, mosquito. Paul Muller, a Nobel Laureate in Physiology or 
Medicine, discovered DDT in 1948 and set forth ambitions for global eradication of 
malaria through spraying with DDT, use of nets and treatment with chloroquine. 
Several European countries completely eradicated endemic malaria. But, the initial 
successes later failed due to social and political factors. In 1969 the global eradication 
policy was abandoned, leading to a resurgence of malaria in 1970s.  
 
Renewed efforts came through the formation of the Roll Back Malaria (RBM) Global 
partnership in late 1998 and the declaration of the Millennium Development Goals 
(A/RES/55/2, 2000). The Roll Back Malaria Partnership reaffirmed its targets through 
the Global Strategic Plan (Roll-Back-Malaria-Partnership, 2005)  that: 
   3 
 
 
• By 2010, through targeting universal coverage: 
− 80% of people at risk from malaria are using Long Acting Insecticide-treated nets (LLINs),  
indoor residual spraying (IRS) 
− 80% of malaria patients are diagnosed and treated with artemisinin-based combination therapy 
(ACTs) 
− in areas of high transmission, 100% of pregnant women receive intermittent  
preventive treatment (IPTp); and 
− the global malaria burden is reduced by 50% from 2000 levels 
 
• By 2015: 
− universal coverage continues with effective interventions; 
− global and national mortality is near zero for all preventable deaths; 
− global incidence reduced by 75% from 2000 levels 
− the malaria-related Millennium Development Goal is achieved: halting and beginning to reverse the 
incidence of malaria by 2015; and 
− at least 8-10 countries currently in the elimination stage will have achieved zero incidence of locally 
transmitted infection. 
 
• Beyond 2015: 
− global and national mortality stays near zero for all preventable deaths; 
− universal coverage (which translates to ~80% utilization) is maintained  
− countries currently in the pre-elimination stage achieve elimination 
 
 
The commitment was echoed by the United Nations Secretary General on the 
occasion of the World Malaria Day 2008, calling for efforts to ensure universal 
coverage with malaria prevention and treatment programmes by the end of 2010 
(WHO, 2009).  
 
 
1.4 ANTIMALARIAL INTERVENTION  STRATEGIES  
In addition to saving lives, malaria control, is highly cost effective because it is 
estimated that, in Africa alone, more than 12 billion USD of direct losses occur per year 
as a result of illness, treatment and premature deaths (WHO, 2009). Since malaria 
affects some of the poorest countries, reducing the malaria burden would result in 
economic benefits that would ultimately reduce poverty (Roll-Back-Malaria-
Partnership, 2008).  
 
The current efforts towards the control and elimination of malaria include the cost-
effective interventions strategies for the prevention and control of malaria i) effective 
case management that includes early diagnosis and treatment of malaria using effective 
antimalarials –the ACTs ii) the use of effective preventive measures such as insecticide 
treated nets (ITN), indoor residual spraying (IRS) and intermittent preventive treatment 
in pregnancy (IPTp) iii) detection and intervention to control malaria epidemics and iv) 
enhancing local capacity for intervention (WHO, 2009).  
 
Effective case management is the cornerstone for the control of malaria (WHO, 2009) 
that aims at reducing mortality through prompt diagnosis and treatment. The strategy 
takes advantage of tools and strategies proven to have a significant impact on 
decreasing malaria mortality. These include the RDTs for malaria diagnosis, which are 
simple to perform and easy to handle in a tropical climate (WHO, 2010a);  the highly 
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efficacious ACTs and the life-saving rectal artesunate for children who could not take 
orally, living in remote rural areas, far placed from health facilities.  
 
By mid-2008, almost all African countries had adopted ACTs as the first-line treatment 
for uncomplicated malaria due to P. falciparum (WHO, 2009). Many African countries 
have rolling-out RDTs as a policy. Wide coverage of malaria interventions has resulted 
in a decline in morbidity and mortality by over 50% in some countries (WHO, 2009). 
While many of these areas were islands such as Sao Tome and Principe and Zanzibar, a 
decline was also reported in some countries in mainland Africa, including Eritrea, 
Rwanda, and Zambia. In countries where a decline of over 50% in malaria cases and 
deaths occurred, a significant drop in under five mortality rates was also reported, thus, 
creating optimism that many African countries might attain the two-third decline in 
child mortality rate (CMR) by 2015, a target set forth in the Millennium Development 
Goals (MDG) (WHO, 2009). 
 
Although the cause of the decline remains obscure, the wide coverage of ITN, IRS and 
ACTs are thought to be the reasons for the decline (WHO, 2009). In addition to 
reducing the bulk of parasite in humans, ACTs has a gametocidal effect which reduced 
transmission of the parasites from human to mosquitoes (Price et al., 2006). The 
dramatic decline in mortality which in some countries was observed within 2-3 years of 
widespread implementation of the three strategies inspired the RBM Partnership to aim 
at eliminating malaria.  
 
Despite the reported achievements, many African countries are still far from achieving 
the targets. The reported decline in malaria mortality was lowest in countries with the 
highest incidence rates (WHO 2009). In 12 African countries where data were 
available, less than 15% of under fives with fever accessed ACTs, figures that are far 
below the RBM Partnership target of 80% (WHO, 2009). The rolling-out of RDTs for 
malaria in endemic countries is challenged by providers’ reluctance to apply the results 
in making clinical decisions (Bjorkman and Martensson, 2010, d’Acremont et al., 
2010).  
 
1.5 THE HEALTH SYSTEM 
Although about two thirds of the deaths in the world are amenable to prevention using 
existing interventions due to the existence of effective and affordable interventions, 
falling prices of drugs and increased funding for many priority health problems in low 
income countries; progress towards agreed health goals remains slow (Becerra-Posada 
et al., 2004). This is partly due to weak health systems in most malaria endemic 
countries that fail to deliver the intervention packages. 
 
Innovative methods for controlling malaria exist, however, success interventions 
depends on a well functioning and efficient health system. The primary bottleneck is 
that the health system is facing severe shortfalls with a demoralized health workforce, 
constant drug shortages, poor coordination of development partners and information 
system (Karamagi et al., 2004, Travis et al., 2004). There is increasing consensus that 
stronger health systems are a key to achieving improved health outcomes. However, 
there is much less agreement on how to strengthen them (Travis et al., 2004). 
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The four functions of the health systems are: governance/stewardship that includes 
accountability, transparency and involvement of key stakeholder; resource 
generation; financing of the health care; and service provision that includes health 
workforce, health information system, drugs and logistic information systems (WHO, 
2000). The ultimate responsibility for the overall performance of a country’s health 
system lies with government, which should involve all sectors of society in its 
stewardship. Stewardship involves defining the vision and direction of the health 
policy, through regulations and advocacy, and collecting and using information 
 
1.5.1 Global governance of malaria control 
A number of stakeholders play an important role at the global level to fight malaria, 
efforts spearheaded by the RBM Partnership whose membership includes the malaria-
endemic countries, development assistance partners, the private sector, research and 
academic institutions. The RBM Partnership aims to reduce malaria morbidity and 
mortality by reaching universal coverage through the strengthening of health systems as 
defined in the global action plan; that is, scaling up for impact (SUFI) of treatment and 
preventive interventions and sustaining control of malaria over time (RBM-Partnership, 
2008b). RBM Partnership also aims to achieve equitable, affordable and sustained 
access to malaria cure and prevention through multi-sectoral approach to reach the 
poorest people by ensuring that cost is not a barrier. The partnership monitors equitable 
coverage and access; and invests in research for evidence based decision making. 
Accountability and transparency are ensured through the Partnership forum that 
involves all stakeholders, where agendas are discussed and recommendations made. 
The Partnership has a Board drawn from all stakeholders and oversees activities of the 
secretariat. The WHO provides leadership for improving the health of all populations 
taking advantage of effective measures, promoting interventions based on necessary 
scientific evidence and articulates evidence based policy options making vulnerable 
groups a priority  (Jong-wook, 2003b). Accountability is ensured through the World 
Health Assembly, the supreme decision making body and an executive board whose 
function is to follow up the WHO secretariat on decisions by the World Health 
Assembly (WHA).  
 
1.5.2 Global financing of malaria control interventions 
The main source of funding for malaria intervention is GFATM; others include 
development assistance partners, international NGOs; and individuals. The GFATM 
was created to contribute towards MDGs by ensuring rapid mobilization of funds 
targeted to the poor and those at risk. In 2009, 55% of the fund was allocated for 
HIV/AIDS and 29% for malaria control. Sub-Saharan Africa received 57% of the fund.  
A commitment of 11.7 USD has been made for Global Fund for 2011-2013  (GFATM, 
2010)  which was more than the previous commitment of  9.7 billion USD in 2000 – 
2010. However, this is still less compared to 5.1 billion USD required annually for 
control interventions between 2011 and 2020 of which Africa alone, needs about 2.7 
billion USD (Roll-Back-Malaria-Partnership, 2008). Accountability by GFATM is 
ensured through performance based funding where an additional fund is provided to the 
recipient upon demonstrating measurable and effective results. This is achieved through 
a rigorous system of measurement and evaluation by empowering local expertise to 
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monitor progress. Transparency is ensured through posting issues related to the Fund 
on the web-site, unedited, and in all languages.  
 
The President’s Malaria Initiative (PMI) started in June 2005 by the United States 
Government with a five-year, $1.2 billion initiative; aims at rapidly scaling-up malaria 
prevention and treatment interventions in high-burden countries in sub-Saharan Africa 
(USAID, 2009). The goal was to reach 85% coverage of the most vulnerable groups 
with ITNs, IRS, IPTp and ACTs. PMI also supports health systems, strengthening 
through training of personnel, information and logistic management. Between 2007 and 
2009, PMI increased ownership and use of ITN by 2-fold in six of the 15 supported 
countries.  There was however a slow increase in the use of ACT. Through the 
President Obama’s Global Health Initiative, expanded PMI with emphasis on strategic 
integration of malaria with other vertical programmes, and strengthening health 
systems to ensure sustainability (USAID, 2009). 
 
1.5.3 Health service delivery 
In the wake of achieving the MDGs the WHO plan is to promote the scaling-up of 
health-care systems based on the principles of primary health care that integrate 
service; building on the Alma-Ata principles of equity, universal access, community 
participation, and inter-sectoral approaches (WHO, 2003). Although the WHO policy 
statement is very clear on its intended direction, this is contradicted in practice by the 
vertical approach in disease control, where the control of major diseases continue to run 
parallel to government systems.  
 
A functioning information system is needed at all levels to monitor health systems’ 
performance. A Health Metric Network (HMN) was launched in 2004, using MDG as a 
platform for strengthening health information systems in low income countries (WHO, 
2010b) to improve the availability and use of health information for policy-making, 
programme monitoring and assessment, monitoring of the Millennium Development 
Goals.  
 
For effective service delivery, the government need to take advantage of existing 
strength from various actors in the country. The private sector contributes significantly 
to the provision of health care including management of malaria in sub-Saharan Africa 
(Goodman et al., 2004, Viberg, 2009). Caretakers prefer private facilities because of 
friendly services with flexible payment conditions (Rutebemberwa et al., 2009c) while 
services at government faculties are not provided all the time, have long waiting times, 
drug shortages and poor provider-caretaker interactions  (Chuma et al., 2009, Goodman 
et al., 2004, Kazembe et al., 2007, Nsungwa-Sabiiti et al., 2005).  However, services 
provided by the private sector are compromised by poor quality and weak regulatory 
mechanisms in many of the malaria endemic countries (Kumaranayake et al., 1997). 
Government policies and strategies to work in partnership with the private sector to 
provide better services that will reach the majority of the people remain on paper 
(MoH&SW, 2007a).  
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1.5.4 Human resources for health  
Higher staff population ratios have been associated with lower child mortality after 
controlling for confounders (Gerein et al., 2006). Over a million trained staff are 
estimated to be required to meet the requirements for the implementation of 
interventions towards the MDGs (Gerein et al., 2006). In some countries such as 
Tanzania, staff numbers will need to be tripled, by 2015 (Kurowski et al., 2004). The 
human resources for the health crisis in African countries are likely to undermine the 
benefits from global commitments and the new technologies becoming available in the 
health sector, thus threatening efforts to attain the MDGs (Gerein et al., 2006, Jong-
wook, 2003b, Narasimhan et al., 2004). 
 
Pay and income is one of the motivating factors influencing performance and staff 
retention. In most malaria endemic countries wages are low, ranging from 70-300 USD 
(Buchan and Sochalski, 2004, Friedman, 2004). This affects retention and distribution 
of health workers, with a wide variation between urban and rural areas and between the 
public and private sector (McCoy et al., 2008). The opportunities to engage in private 
practice, extracting informal fees from their patients, or seeking per-diem payments by 
attending workshops and seminars (Roenen et al., 1997) favours staff retention in urban 
areas making understaffing worse in rural and primary level facilities (Gerein et al., 
2006).  
 
The RBM Partnership aims to ensure investments are made to enable countries to 
mobilize, retain and motivate highly qualified individuals to manage malaria control. 
(Roll-Back-Malaria-Partnership, 2005). However, employees’ pay is influenced by the 
ability of the government to pay. Although sub-Saharan Africa has fewer staff as a 
percentage of the population, staff payment consumes a higher proportion of GDP 
compared to other developing countries (Schiavo–Campo et al., 1997). Increasing staff 
payment will lead to an increase in government spending on human resources leaving a 
smaller proportion of the budget for drugs and other recurring expenditure (McCoy et 
al., 2008). This will lead to a large unsustained fiscal deficit which was part of the 
reason for structural adjustment in the 1980s and 1990s that led to retrenchment and the 
freezing of hiring staff (Haque and Aziz, 1998) and consequently a shortage in the 
health workforce (Lienert and Modi, 1997). Strategy to raise health staff salaries 
through increasing the government budget to health is unlikely for many African 
countries that are still struggling to reach the Abuja target of 15% (McCoy et al., 2008). 
Increasing government revenue, is limited by the low tax-base, revenues in sub-Saharan 
Africa countries contribute an average of only 15% of the GDP, compared to high 
income countries (30-40%) (McCoy et al., 2008). Raising salaries through external 
support is not sustainable once grants are withdrawn. This leads to a stalemate where 
governments are unable to remunerate health staff and they in turn are not motivated to 
deliver, with the rural areas bearing the brunt. 
 
1.5.5 Drugs procurement and distribution 
In the effort to find alternative drugs to ACTs, the RBM Partnership fostered the 
creation of the Medicines for Malaria Venture (MMV) a public-private partnership that 
unites public and private sectors to fund and provide managerial and logistic support 
for research and development of new medicines to treat and prevent malaria. RBM 
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Partnership also works with the agricultural sector to increase the availability of 
Artemisia annua for the production of ACTs (Roll-Back-Malaria-Partnership, 2005).  
 
Dealing with high volumes of drugs with few manufacturers for organic substances that 
require planting is challenging.  The RBM Partnership has set up a malaria commodity 
procurement support system, Malaria Medicines and Supplies Service (MMSS), which 
seeks to remove barriers preventing required volumes of the  malaria commodities 
needed from reaching countries (Roll-Back-Malaria-Partnership, 2005). The MMSS, 
assists in global forecasting, procurement and supply mechanisms, and make direct 
contact with manufacturers to overcome the challenges of the rapid increase in 
demands for anti-malarial medicines, diagnostics and bed-nets (Roll-Back-Malaria-
Partnership, 2005). 
 
Recently, the Affordable Medicine Facility for malaria (AMFm) initiative was started 
with the aim of availing ACTs through the private sector by applying a subsidy at the 
manufacturers’ level. This is likely to reduce the price of ACTs to that of previous 
antimalarials (RBM-Partnership, 2007b). 
 
1.6 MALARIA TREATMENT 
While treatment with ACTs aims to cure patients with uncomplicated malaria which, if 
not well treated, might result in a severe condition and ultimately death or drug 
resistance, treatment of severe malaria aims at reducing mortality. In addition, to 
reducing the bulk of parasites circulating in the community the artemisinin component 
of ACTs has a gametocidal effect that reduces malaria transmission. Proper treatment 
of malaria requires making a correct diagnosis; in clinical practice, this is done mainly 
using microscopy or RDTs for malaria. Understanding the treatment of malaria requires 
background knowledge on treatment policy; characteristics of antimalarials used and 
drug pharmacokinetics and pharmacodynamics. 
 
1.6.1 Malaria treatment policy 
Diagnostics – Microscopy and RDT 
 
Until recently, presumptive diagnosis of malaria was recommended to be treated with 
ACTs (MoH&SW, 2006, WHO, 2006). Currently, the WHO recommends the use of 
RDTs and microscopy for the diagnosis of malaria and only where these facilities are 
not available that the presumptive diagnosis of fever suspected to be of malaria can be 
used (WHO, 2010a). The use of diagnostics reduces the unnecessary prescriptions of 
antimalarials and is thus cost effective (Guerra et al., 2008, Ngasala et al., 2008, 
Shillcutt et al., 2008). In addition, the risk of misdiagnosing other severe febrile 
illnesses with fatal outcomes is reduced (d’Acremont et al., 2010, Drakeley and 
Reyburn, 2009, Hildenwall et al., 2007).  
 
Microscopy is the gold standard, used for species diagnosis, quantification, assessment 
of response to treatment and diagnosis of other causes of fever (WHO, 2010a). 
However, major variations between readers can occur, especially, if personnel are not 
well trained (Ngasala et al., 2008). RDTs are comparatively easy to use, require 
minimal training and are cost-effective (Lubell et al., 2007, Mayxay et al., 2004, 
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Shillcutt et al., 2008). Thus, RDTs can be used in rural facilities and by CHWs with an 
acceptable quality of results (Mubi et al., 2010). However, false negative results lead to 
some patients with negative RDT results being treated with ACTs (Hamer et al., 2007, 
Reyburn et al., 2007), despite evidence that withholding treatment in these children is 
safe even in endemic areas (d’Acremont et al., 2010, Njama-Meya et al., 2007). 
However, it takes time for a new policy change to diffuse before people can implement 
(Eriksen et al., 2005).  
 
Available tests include Plasmodium falciparum antigen based on histidine rich protein 
(HRP2) and an enzyme parasite lactate dehydrogenase (pLDH) which detects all four 
human Plasmodium species. The former, are generally more sensitive but with a 
relatively low specificity (Hopkins et al., 2007) which can persist in 35-73% cases  
after two weeks (Abeku et al., 2008, Swarthout et al., 2007). HRP2 is recommended in 
endemic areas where P. falciparum is dominant, due to the relatively low cost, high 
sensitivity and stability compared to pLDH (Abeku et al., 2008, Mayxay et al., 2004). 
 
The WHO malaria treatment policy 
 
The recommended treatments for uncomplicated malaria are ACTs that include 
artemether plus lumefantrine, artesunate plus amodiaquine, artesunate plus 
mefloquine, artesunate plus sulfadoxine-pyrimethamine and dihydroartemisinin plus 
piperaquine (WHO, 2010a). The recommended treatment for severe malaria in 
children, especially in the malaria endemic areas of Africa, is any of the following 
antimalarials administered for a minimum of 24 hours; intravenous artesunate or 
intramuscular quinine,  intravenous infusion or divided intramuscular injection; 
intramuscular artemether, used if none of the alternatives are available. The WHO 
also recommends that patients should be given pre-referral treatment using rectal 
artesunate, intramuscular quinine, intramuscular artesunate or intramuscular 
artemether and immediate referral to an appropriate facility for further treatment if 
complete treatment of severe malaria is not possible.  
 
1.6.2 Recommended antimalarials for uncomplicated and severe 
malaria 
Artemether-Lumefantrine combination 
 
ALu is a combination of artemether and lumefantrine, both originally developed in 
China. ALu has efficacy greater than 95% (Lefévre et al., 2001, van Vugt et al., 1999). 
The 6-dose regimen kills a maximum of two asexual life cycles. ALu is given in six 
doses (Table 1) spread over three days at 8, 24, 36, 48 and 60 hours after the initial dose 
(WHO, 2010a). Studies have not been conducted in infants less than 5kg (White et al., 
1999). ALu tablets are not light sensitive and are stable at temperatures <30°C for at 
least 2 years (White et al., 1999). Recently, a dispersible form for children with 
uncomplicated malaria  has been shown to have similar high response rates compared 
to crushed ALu tablets (Abdulla et al., 2008).  
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Artesunate 
 
Artesunate is a semi-synthetic derivative of Artemisinin, being water soluble it can be 
formulated as oral, rectal, intramuscular, and intravenous preparations. Unlike 
intravenous quinine, intravenous artesunate has less risk of low blood sugar (Jones et 
al., 2007) and thus causes a 35% reduction in the risk of mortality in the treatment of 
severe malaria (WHO, 2010a). However, there is not enough evidence of its 
effectiveness and potential adverse effects in children in Africa who carry the highest 
burden (Jones et al., 2007). As mono-therapy, its use in malaria endemic settings is 
challenged by the need of an extended administration period which may lead to non-
compliance (Noedl et al., 2008). However, this is unlikely with rectal artesunate 
strategy where a single dose is given followed by immediate referral. Rectal artesunate 
is thermo-stable, kills parasites fast , has high bioavailability and is safe (Awad et al., 
2003). A formative study done in Mtwara showed that rectal application of medicine 
was familiar and acceptable by community members (Warsame et al., 2007).  
 
1.6.3 Pharmacokinetics/dynamics of artemisinin-lumefantrine 
Artemether provides a rapid reduction of parasitaemia by over 90% within 24 hours, 
almost completely after 36 hours (White et al., 1999) and is responsible for the 
dramatic improvement in malaria patients. It further inhibits younger gametocytes 
(Table 1), thus, decreasing malaria transmission (Barnes et al., 2005). Artemether is 
absorbed rapidly and bio transformed to dihydroartemisinin, and both are active and 
eliminated fast (White et al., 1999).  
 
Lumefantrine acts late to slowly kill the residual parasites. It is eliminated slowly and 
absorption depends on fat which increases bioavailability 16-fold (White et al., 1999) 
thus explaining the wide variation among individuals. Blood lumefantrine 
concentrations are measured using HPLC in serum, plasma or whole blood (van Vugt 
et al., 1998, Zeng et al., 1996). Plasma lumefantrine concentration on day 7 is a good 
determinant of therapeutic response (White et al., 1999), a concentration of 280 µg/L 
(524 nmol/L) on day 7 was found to predict cure (White et al., 1999), hence adherence 
to ALu treatment. However, background immunity of the patient facilitates parasite 
clearance and patients can be cured at less than 175 µg /L (331 nmol/L) in African 
settings (Bell et al., 2009). 
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Table 1: Characteristics of some of the recommended antimalarials  
Drug Indication Formulations Dosage Side-effect Action Half-life 
SP Intermittent 
Preventive 
Treatment in 
pregnancy 
Tables 
Syrup 
500 mg of 
sulphadoxine and 25 
mg of pyrimethmine 
Steven-Johnson 
sysndrome, 
Hepatitis, hemolysis, 
skin rash and 
megaloblastic 
anaemia 
Schizontocidal Sulphadoxine 
125 hrs 
Pyrimethamine 
80-95 hrs 
ALu Uncomplicated 
malaria 
Tablets 
Dispersible 
Six dose of 
artemether 20mg and 
lumefantrine 120mg.; 
25-35kg each dose is 
3 tablets, 
15 to 25kg, 2 tablets 
and <15kg, one tablet 
Similar to malaria 
symptoms 
Schizontocidal 
Gametocidal 
Artemether 2-3 
hrs 
Lumefantrine  3-
5 days 
Artesunate  Severe malaria Rectal 
suppositories 
Intravenous 
Intramuscular 
2.4 mg/kg loading 
dose over 5 minutes  
1.2 mg/kg dose 12 
hours later  
1.2 mg/kg once daily 
after that  
Less severe compared 
to quinine 
Schizontocidal 
Gametocidal 
1 hour 
Quinine Severe malaria Tablets 
Syrup 
Intravenous 
Intramuscular 
Rectal 
10 mg/kg 8 hourly for 
7 days 
Hypoglycaemia 
Blood dyscrasias 
Cinchonism 
Schizontocidal 7-11 hrs 
 
1.6.4 Antimalarial drug resistance  
Drug resistance poses a major threat to the control of malaria due to high mortality in 
Africa (WHO, 2009). Mortality among children treated with chloroquine was reported 
to increase 2 to 11-fold in areas with resistance (Trape, 2001, Zucker et al., 2003). This 
was observed even where efficient health services have been achieved (Trape, 2001). 
The high levels of resistance to switch to alternative drugs (25%) might have 
contributed to high mortality; this has been revised by WHO and lowered to 10% 
(WHO, 2010a). 
 
Plasmodium falciparum malaria partial resistance to artemisinin has emerged on the 
Cambodia–Thailand border (Dondorp et al., 2010) attributed to artemisinin mono-
therapies and the use of sub therapeutic doses and substandard artemisinins.  
The situation presents a major public health threat, especially, in high transmission 
areas where the impact could be high, yet difficult to quantify because of the prolonged 
asymptomatic infections (Bjorkman and Bhattarai, 2005). Measures to contain the 
emergence of resistance includes increasing access to effective and affordable drugs in 
rural communities where the burden is high and ensuring adherence to the treatment 
schedule (Marsh, 1998). Other strategies include optimizing vector control, targeting 
the mobile population, strengthening management and surveillance systems, and 
operational research (Dondorp et al., 2010). 
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1.7 CHALLENGES IN MANAGING MALARIA IN UNDER FIVES  
1.7.1 Prompt access to artemisinin-based combination therapy  
Prior to drug policy changes, it was cautioned that when switching to ACTs, strategies 
must be instituted to ensure that the poorest groups are not marginalized (Hetzel et al., 
2006, Njau et al., 2006). Subsidy limited to public facilities, might force caretakers to 
seek care from public facilities. Concerns have been raised about the quality of services 
provided in government facilities. These include services  not being provided all the 
time, long waiting times and poor provider-patient interaction (Chuma et al., 2009, 
Kazembe et al., 2007, Nsungwa-Sabiiti et al., 2005). There has also been concern that 
when new interventions are introduced it is the better-off who tend to benefit 
(Schellenberg et al., 2003, Victora et al., 2004) and that caretakers often tend to seek  
cheaper alternatives for treatment and go to health facilities only when the condition is 
serious (Nyamongo, 1999, Rutebemberwa et al., 2009c). 
 
Recent studies reported that prompt access to ACTs was not more than 15%, despite a 
policy change (Gitonga et al., 2008, Tipke et al., 2009, WHO, 2009). Studies carried 
out when CQ and SP were the first line drug reported several factors that influenced 
lack of prompt access to antimalarials, these included, drug shortages, sources of care 
and distance to the health facilities (Chuma et al., 2009, Rutebemberwa et al., 2009a).  
 
A strategy to improve prompt access to antimalarial was the involvement of the private 
sector where drug shops in Tanzania were upgraded to Accredited Drug Dispensing 
Outlets (ADDOs) and allowed to dispense a selected number of essential prescription 
only drugs, including ALu. A study conducted in Tanzania in which private facilities 
were provided with subsidised ALu reported a significant rise in the purchase of ACT, 
from 1% to 44% compared to the control (Sabot et al., 2009). However, the study did 
not report the residence and social economic status of the patients.  
 
1.7.2 Community-based health care  
Task shifting by having some of the specialized tasks performed by lower cadres can be 
cost saving (McCoy et al., 2008). Community-Based Health Care (CBHC) is one of the 
practical strategies to reach the majority of the people in rural areas (Ajayi et al., 2008a, 
Haines et al., 2007, Onwujekwe et al., 2007). Home-based malaria treatment through 
CBHC has been reported to increase access to and effectiveness of antimalarials (Ajayi 
et al., 2008a, Nsungwa-Sabiiti et al., 2007, Smith et al., 2009).  
 
HMM was implemented in Uganda using volunteer community drug distributors 
(CDDs) who provided free pre-packaged CQ-SP (Homapak), based on presumptive 
diagnosis, and educated mothers on correct treatment. A modest change in practice 
(13.5%) was observed with community effectiveness of only 25% (Nsungwa-Sabiiti et 
al., 2005). Reasons for the limited success were CHWs providing malaria treatment 
only and introducing two new policies at the same time, that is, the malaria drug 
combination and HMM. Other reasons were lack of appropriate sensitization and 
education of the communities and possible lack of personnel to provide adequate 
supervision and sensitization (Smith et al., 2009). A similar study conducted in Burkina 
Faso reported an increased prompt access to effective antimalarial treatment by more 
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than 2-fold, at a minimal intervention costs of 0.06 USD per child (Pagnoni et al., 
1997). The WHO is currently working on integrating home-based treatment of 
malaria into the Community Case Management (iCCM) of childhood illnesses  
(WHO, 2010a). The new strategy seeks to integrate three major killer diseases that is 
malaria, pneumonia and diarrhoea into a community based care programme with a 
view to reducing child mortality, which together, claims about 4 million under five 
deaths each year (UNICEF, 2010). 
 
Despite the potential contribution, effective CBHC demands a well functioning health 
system to supervise and maintain continuing education (WHO, 2008). The success 
hitherto observed in Uganda might not be realized on a national scale and that observed 
in Burkina Faso might have been attributed to the presence of the research team.  In 
addition, the strategy is challenged by the inability to sustain CHWs (Kironde and 
Klaasen, 2002). Although, in theory, CHWs have worked as volunteers, there has been 
a growing demand and concerns for incentives. In some projects this has been provided 
in the form of self payment through cost recovery of the drugs they dispense and 
performance based incentives, especially, when working with vertical programmes 
(Soeters and Griffiths, 2003). However, this modality might not be sustainable on a 
large national level scale. This led to some researchers to conclude that improving 
access within hospitals and clinics should be a major priority (Smith et al., 2009).  
 
1.7.3 Adherence to treatment schedule  
Prompt access alone is not enough, caretakers have to adhere to a treatment schedule in 
order to achieve cure (Brugha et al., 1999). In addition to the need for increasing 
prompt access, policy change to ACTs also poses a challenge to adherence to treatment. 
The limited subsidy that limits availability, complex dosing and high drug efficacy that 
causes dramatic cessation of symptoms,  might prompt caretakers to discontinue 
treatment and save the remaining drugs for future use  (Hinton et al., 2007, Makanga et 
al., 2006). Failure to adhere to the treatment schedule would lead to resistance to ACT, 
the last in the armaments of antimalarials for treating uncomplicated malaria.  
 
Few community based studies have been conducted on adherence to ACTs in the 
African countries; this is partly because the drug has been adopted quite recently. 
Nevertheless, quite high levels of adherence were reported (Ajayi et al., 2008b, Beer et 
al., 2009, Kabanywanyi et al., 2010). Some of the factors deterring caretakers’ 
adherence to previous antimalarial treatment included emic local perception about the 
disease (Nsungwa-Sabiiti et al., 2004), lack of basic education  (Beer et al., 2009, Fogg 
et al., 2004) and understanding the importance of adhering to a treatment schedule 
(Yeung and White, 2005); and caretakers’ forgetfulness (Beer et al., 2009). Non-
adherence to antimalarials has been associated with provision of inadequate doses 
(Yeung and White, 2005) and low drug efficacy (Chuma et al., 2009, Yeung and White, 
2005). Providing information and education to caretakers on correct drug use (Okeke, 
2010), use of pictorial instruction (Fogg et al., 2004) and pre-packaged tablets with 
proper labelling (Agyepong et al., 2002, Ansah et al., 2001) have been associated with 
adherence to treatment.  
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1.7.4 Adherence to referral advice 
Normally, patients are expected to start treatment at a lower level of service delivery to 
be cost-effective (Segall, 2003). However, while in urban areas there is overuse of 
referral facilities, in rural areas there is inadequate use (Kalter et al., 2003). Children 
with severe malaria need to be treated at higher level facilities or hospital (Simoes et 
al., 2003) where parenteral treatment can be administered (Gomes et al., 2008, WHO, 
2010a). However, many of the children die before reaching referral facilities or soon 
after (de Savigny et al., 2004) if appropriate treatment is not obtained within 24 to 48 
hours (Breman, 2001). Since  most children with severe symptoms in rural remote areas 
are at more risk of dying, the WHO recommended pre-referral treatment with rectal 
artesunate and RDTs for home based management of malaria, where feasible (WHO, 
2010a). The success of this strategy, however, depends on adherence to referral advice 
which is challenged  by the weak referral system in malaria endemic areas (de Savigny 
et al., 2004, Font et al., 2002, Petterson et al., 2004). Failure to adhere to referral advice 
might lead to delay in identification and treatment of other different or overlapping 
febrile conditions (Gomes et al., 2008, Kallander et al., 2004). Some factors reported to 
influence adherence to referral advice include severity of the illness, need for 
permission to make the journey to the clinic and the associated costs. Other factors 
included household chores, perceived quality of hospital care and health workers’ 
communication skills (de Zoysa et al., 1998, Kalter et al., 2003).  
 
1.8 TANZANIA COUNTRY PROFILE 
The United Republic of Tanzania was formed by a union of two states, Tanzania 
mainland and Zanzibar and is one of the five countries in East Africa; others are Kenya, 
Uganda, Rwanda and Burundi. The country is located between longitude 290 and 410 
east and latitude 10 and 120 south and it is bordered by the Indian Ocean in the east, the 
Democratic Republic of Congo, Rwanda and Burundi in the west; Kenya and Uganda 
in the north and Zambia, Malawi and Mozambique in the south. The country’s 
population is estimated to be over 44 million (National-Bureau-of-Statistics, 2006) and 
spreads over an area of about 945,000  sq. km. making it larger than all the other East 
African countries put together. It is divided into 21 regions and 137 districts, recently 
three regions were added, see Figure 2.  
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Figure 2: A map of Tanzania showing study sites (I-IV)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.8.1 Economic characteristics 
With a GDP per capita of 542 USD (IMF, 2010) and a quarter (25%) of the people 
living below the poverty line, Tanzania is classified as one of the least developed 
countries (World Bank Report 2007). The level of poverty is higher in rural areas 
where over one-third (37%) of the people live below the poverty line compared to 
urban areas (18%) (National-Bureau-of-Statistics, 2002). The majority (85%) of the 
population lives in rural areas and depends on agricultural activities as their main 
source of income. 
 
Kilosa 
Mtwara (R) 
Kilosa 
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1.8.2 Demographic characteristics 
The demographic characteristics in Tanzania are typical of a low income country with a 
growth rate of 2.9% (National Census) and total fertility rate (TFR) of 5.4 births per 
woman, see Table 2 (National-Bureau-of-Statistics, 2010). TFR is almost twice as high 
in rural areas (6.1) compared to urban areas (3.7). The rate has not changed from that 
estimated in 1996. The life expectancy at birth for a Tanzanian is 52 years. The infant 
mortality rate and the under five mortality rate have been declining since 1996 despite 
the HIV/AIDS epidemic that started in the country in 1983. The country has 
unfavourably high maternal mortality rates which have remained high throughout the 
period (Table 2). About 70% of the population lives in rural areas and 25% of the 
women and 10% men have not attended school (National-Bureau-of-Statistics, 2010). 
 
Table 2: Tanzania demographic indicators (Source TDHS) 
Indicator 1996 1999 2004 2009 
Under five  mortality rate (deaths/1,000 live 
births) 
137 147 112 81 
Infant mortality rate (deaths/1,000 live births) 88 99 68 51 
Neonatal mortality rate (deaths/1,000 live births) 32 36 32 26 
Children under weight (%)  30 29 22 21 
Stunting (%)  44 44 38 35 
Total fertility rate (number of children women 
bear in lifetime) 
5.8 5.6 5.7 5.4 
Maternal mortality ratio per 100,000 live-births 529 … 578 454 
HIV Prevalence (%) ... ….. 7 6 
Children under five with fever last 2 weeks (%) 28.1 35.0 16.8 23.0 
Children under five with cough accompanied with 
fast breathing last 2 weeks (%) 
13.0 13.8 6.1 4.0 
Children under five with diarrhoea last 2 weeks 13.7 12.0 7.4 15.0 
 
 
1.8.3 Health care system  
Structure and organisation of the health care system 
 
There are 5,178 dispensaries, 737 health centres and 420 hospitals (MoH&SW, 2008a). 
Of these 67% of the facilities are government owned. There are more than 8,000 drug 
shops in the country (Goodman et al., 2009) which are now in the process of being 
transformed to ADDO. Ordinary shops, those selling household merchandize, also 
stock and sell drugs such as analgesics.  
 
The health care systems in the country are organised in a hierarchy from the 
community to the national level (Figure 3). The health care system is decentralised at 
the district level where a four level tier system operates. At the community level there 
is a village health post supposed to be run by CHWs. Many of them function on an ad 
hoc basis. There are two CHWs per village, one male and another female. At the ward 
level there is a dispensary that caters for about 3-5 villages with a catchment population 
of about 10,000 people. A dispensary is normally run by one assistant clinical officer 
and one public health nurse. At the level of division, there is a health centre that serves 
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a catchment population of about 50,000 people. In addition to outpatient services 
offered at the dispensary level, health centres also offer laboratory and in-patient 
services. They are staffed by 3-5 clinical officers, several enrolled nurses and medical 
attendants. There is a district hospital that serves as a referral facility for the 
dispensaries as well as the health centres.  
 
Figure 3: Organisation structure of the health system in Tanzania 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policy context  
 
The history of health services in Tanzania starts from the colonial period where the 
private providers of health services, mainly religious organisations, provided most of 
the services (MOH&SW, 1994). The Arusha declaration in 1967, reformed the country 
into a state planned economy where health services were to be provided free of charge 
at all levels (Semali, 2003). Private facilities and practice was banned, unless operating 
under the auspices of religious organisations.  Even before the Alma Ata declaration in 
1978 the country reshaped the health services with a focus to the rural areas, building 
and equipping dispensaries in villages, putting emphasis on preventive services and 
community participation (Semali, 2003). The coming of the Alma Ata with the PHC 
saw the introduction of the VHWs programme in the country. Two VHWs were 
selected by community leaders in each village to provide preventive care as well as 
treating minor illnesses. The structural adjustment policies that came in the 1990s, 
following a change in the economic set-up, from state planned to free market economy, 
saw the lifting on the ban of private practice (MOH&SW, 1994). This was followed by 
health sector reforms in which cost sharing was gradually introduced and other 
alternative mechanisms for health care financing initiated, that is CHF and NHIF 
(MOH&SW, 1994). As a consequence of the structural adjustment programme, the 
health sector faced a period of stagnation. Due to severe under funding of health 
services, health facilities were faced with severe shortages of essential drugs, 
National 
and 
Referral 
hospital 
Regional Hospitals 
District Hospital 
Health centres – Division level 
Dispensaries – Ward level 
Village health post – Village level 
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equipment and supplies. Staff retrenchment that came with the economic reforms, 
severely affected the health sector and has not recovered, to date. 
  
Since the turn of the century, a number of policy decisions have been made and 
strategies formulated, that shaped the direction of health care services in the country, as 
shown in Table 3. 
 
Table 3 Policy decisions and strategies that influence the provision of health 
services in Tanzania 
Strategy Year Focus on  Target 
Vision 2025 2000 -high quality of livelihood 
-access to quality primary health care for all 
Become a middle income 
country by 2025 
MKUKUTA 2005 -improve the quality of life and social well being  
-reduce disparities in access to and use of social services 
between the better-offs and the poor and between urban 
and rural population and 
-operational and effective service delivery agreements 
-Reduce basic need poverty 
from 38.6% in 2000/01 to 
24% in 2010 with a focus 
on rural areas 
-Reducing IMR from 95 in 
2002 to 50 in 2010 and <5 
MR from 154 to 79 per 
1000 live births 
The National 
Health Policy 
2000 -providing primary health care using essential health care 
package through a decentralised health system devolved to 
the Councils  
-having a well-planned, trained and deployed workforce, 
remunerate and support health workers adequately  
-incorporate other financing mechanisms such as user-fees, 
insurance and community health fund 
 
Health Sector 
Reform 
(HSR): Plan 
of Work 
1997 -improve access, quality and efficiency in health services  
-strengthening decentralised district health services  
-ensuring basic health services are available and accessible 
to all 
 
The Primary 
Health Care 
Service 
Development 
Programme 
(MMAM 
2007 Accelerating provision of primary health care for all by 
2017. 
Rehabilitating and 
constructing new health 
facilities to have a 
dispensary in each village 
and a health centre in each 
ward 
The Health 
Sector 
Strategic 
Framework 
(HSSP III): 
2009 -strengthening; referral system and district health services  
-increasing accessibility to health services  
-maximize effective utilization of human resource for 
health;  
-partnership with the private sector  
-disease prevention and control of priority diseases that 
includes malaria, TB and HIV/AIDS  
-universal access to intervention 
 
 
   19 
Governance 
 
National level 
 
The Ministry of Health and Social Welfare (MoH&SW) is responsible for policy 
making, monitoring, supervision and reinforcement of technical issues related to 
health in the country. The day to day management of activities is decentralised to the 
districts, called Councils, answerable to the Prime Minister’s Office for Regional 
Administration and Local Government (PMORALG). This sometimes creates a lack 
of clarity regarding the authority boundaries between these two policy making bodies 
(MoH&SW, 2007a). 
 
Performance monitoring is conducted effectively at the national level through joint 
annual joint reviews that involve stakeholders from government, NGO and 
development partners. The joint reviews are preceded by technical reviews, conducted 
by consultants, which give an independent opinion of the health situation in the 
country. Periodically, joint evaluations are conducted with the involvement of external 
consultants. Compiled indicators include milestone to MDG, MKUKUTA, MTEF, 
PER, performance at the Council level and human resources issues. These are 
disseminated to stakeholders annually and used during review meetings to discuss 
progress in the performance of the health sector. These mechanisms raise the level of 
accountability and transparency at the national level. 
 
District level 
 
Each district, township, municipality and city has a health team known as the Council 
Health Management Team (CHMT) led by the Council (District) Medical Officer 
(DMO). The CHMT is responsible for planning, organising and monitoring delivery of 
health care services in the district. The CHMTs work under the Council Health 
Service Boards (CHSB), whose membership is derived from the community. The 
heads of departments, including the DMO, reports to the District Executive Director 
(DED) who is the overall in-charge of all sectors. The DED in turn is accountable to the 
District Council which comprises of Counsellors elected by the people.  
  
The role of the district is to implement health interventions as outlined in the policy 
guidelines. The districts prepare Comprehensive Council Health Plans and implement 
them after endorsement by the Councils. Accountability is through quarterly Council,  
CHSB and CHF Board meetings. It is however, reported that the functioning of 
accountability structures are weak (MoH&SW, 2007a). With the exception the Council, 
board meetings are irregular or by-passed (MoH&SW, 2007a). The discussions during 
Council meetings lack mechanisms for accountability and transparency as rigorous as 
those at national level, where evidence based information compiled by independent 
reviewers is used as the basis for discussions by key stakeholders. 
 
Health facility level  
 
The health boards are mandated through by-laws to oversee health care provision in 
the respective districts. At the primary health facility level, there are Health Facility 
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Governing Committees, with representation from the community, whose 
responsibility is to oversee the provision of health services in the respective health 
facilities. While these structures have been formed to ensure accountability through 
community representations they are sometimes by-passed by technical staff in the 
decision making processes (MoH&SW, 2007a). 
 
Financing the health care  
 
National level  
 
There has been an increase in government funding in the health sector which has 
increased from 3.5 USD per capita in 1993 during the structural adjustment policy 
(MoH&SW, 2007a) to 11.2 USD in 2009 (MoH&SW, 2009a). Adding the 
contribution from development partners, the per capita expenditure is 15 USD 
(MoH&SW, 2009a). The increase however, is still lower than the optimum WHO’s 
estimated per capita spending on health of 34 USD per capita. Measured as a share of 
total Government spending on health, there has been a slight increase from 9% in 
2000 to (MoH&SW, 2008a) about 10% (MoH&SW, 2009a), which is lower than 15% 
commitment made in Abuja by African countries in 2005.  
 
The government is the largest source of public spending on health; however, external 
resources are significant, accounting for up to 37% of the total expenditures. User fee 
revenues, although a relatively small proportion of the contribution, are an important 
source of funding in the facilities where it is collected and spent. The proportion of 
development expenditure, largely contributed to by the development partners has 
increased from about 20% in 2004/05 to about 45% of estimates in 2008/09. Although 
most funds from development partners were previously channeled through the basket 
fund, the ratio has reversed from 5:1 in 2004 to 1:2 in 2007 (MoH&SW, 2009a). 
Disbursing a large share of the fund outside the basket fund distorts the Ministry and 
Council plans and might contribute to the reported slow pace in reaching some of the 
targets.  
 
District level 
 
Provision of health services at the district level is financed through 13 different 
sources (MoH&SW, 2007a). Block grant from the central Government to the Council 
accounts for 47% of the health budget; about 80% is for salaries and other employee’s 
benefits, leaving merely 20% for other costs. Health Basket Fund (HBF) contributed 
by development partners is the second major source of fund accounting for 14.4% of 
the district health budget. User fees have been charged in hospitals since 1993, the 
fees have been introduced gradually in primary health facilities, where patients pay 
one USD for a disease episode. User fees apply only as a parallel payment system for 
non-members where CHF has started. A waiver policy has been instituted by the 
MoH&SW, among others, services provided to children under five. About half 
(72/137) of the districts have started CHF since its commencement in 1998. 
Operating on a voluntary basis for rural households, only 6% of the population in the 
country were enrolled in by 2008 (MoH&SW, 2009a).  This is unlike the National 
Health Insurance Fund (NHIF) which is mandatory for public servants. In 2007/8 the 
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fund was able to collect over 50 million USD of which, only 15% were used for 
refund (MoH&SW, 2007a). Decentralisation to the district is compromised by the fact 
that more than half of the health budget is controlled at the MoH&SW headquarters 
(MoH&SW, 2007a). The large number of funding sources also increases bureaucracy 
making accountability and transparency more cumbersome. 
 
Human resources for health crisis in the country  
 
The human resource workforce was 29,000 staff in 2006 with almost half of them 
untrained staff (MoH&SW, 2008a). Staff shortages started with staff retrenchment in 
1994 followed by a 10-year freezing of staff recruitment which was part of a structural 
adjustment programme. Only 35% of the required work force was in place in the 
country, in 2006 (MoH&SW, 2007a). A wide variation exists between regions, with 
the highest having almost seven times staff population ratio compared to the lowest 
region, in 2006. This reflects differences in the ability to retain recruited staff with more 
advantage in urbanized areas. Although there has been an increase in the number of 
students enrolled in health training institutions and those posted to Councils, there has 
been no noticeable increase in staff numbers, because, this has only enabled the 
replacement of staff as a result of  normal attrition (MoH&SW, 2009a). Recruited staffs 
are not retained due to delays in receiving their first salary; this favours staff retention 
in urban areas, where there are alternative means of survival. 
 
Staffing is complicated by the number of stakeholders involved that includes local 
governments that recruit; the PMORALG dealing with career development including 
promotion, MoH&SW for technical health issues, Department of Human Resource of 
the Presidents Office for human resource planning and the Ministry of Finance for 
paying salaries and other benefits. Staffing problems are compounded by deficiencies 
in accountability, absenteeism and productivity (MoH&SW, 2009a). A result based 
bonus scheme and pay on performance basis advocated by MoH&SW, with priority to 
rural areas, is yet to be implemented at the district level. Some of the challenges to 
implement include an inadequate routine information system and supervision 
necessary for a fair and transparent performance measurement and reward.  
 
Drug procurement and distribution  
 
The Medical Stores Department (MSD), an autonomous Government agency under 
the Ministry procures and distributes drugs and supplies to government and FBO 
facilities based on a list of essential drugs. Drug distribution has been changed from 
kit ‘push’ to indent system ‘pull’ where facilities order drugs according to their 
requirements. Despite the initiatives, stock outs of essential commodities are common 
and sometimes accompanied by expiry of excess stocks (MoH&SW, 2009b, 
MoH&SW, 2009a). This indicates an inadequate logistics information system as well 
as inadequate supportive supervision. While facilities are allowed to purchase drugs 
whenever there is a shortage, using funds collected through user fees and CHF, 
lengthy bureaucracy in accessing funds and procuring drugs undermines the system. 
Drugs supplied through vertical programmes, including ALu, are allowed to bypass 
the bureaucratic system,  hence, shortages rarely occur (MoH&SW, 2007a). 
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Drug shops are the commonest source of drugs, but these are mostly located in urban 
and semi-urban areas. Although they are supposed to sell over-the-counter drugs 
only, prescription drugs can also be obtained (Viberg, 2009). Currently the 
MoH&SW is rolling out nationwide the ADDOs where drug shops are allowed to sell 
a selected number of prescription-only drugs including ALu after training on good 
pharmaceutical practice (Moon et al., 2009). Ordinary shops that sell household 
goods also sells drugs, and are often the only source of drugs in rural remote areas 
(Goodman 2004) 
 
1.8.4 Malaria control in Tanzania - Mainland 
Malaria burden  
 
In the Tanzania Mainland, malaria is the leading cause of morbidity and mortality 
(MoH&SW, 2008a). With 93% of the population at risk of malaria, approximately 16 
million clinical malaria cases occur, accounting for about 30% of outpatient 
attendances. Malaria deaths are estimated to be 60,000 and accounts for approximately 
15% of deaths among children admitted in hospitals. Over 80% of malaria occurs 
among children under five years of age (National-Bureau-of-Statistics, 2005). A decline 
in the percent of children under five reported to have had fever in the past two weeks 
from 35% in 1999 to 23% in 2009 is seen in Figure 2 (MoH&SW, 2009a) with a 
stagnation between 2004 and 2009. The burden of malaria was higher in rural areas 
(19.7%) compared to urban areas (8.1%), in 2007 (MoH&SW, 2008b). Compared to 
the Mainland, Zanzibar has made great achievements in controlling malaria. With all 
1.2 million people in Zanzibar (100%) at risk of getting malaria (National-Bureau-of-
Statistics, 2006), the prevalence has declined from 40.3% in 1996 to 0.8% with a slide  
of <5%, in  2007-08 (National-Bureau-of-Statistics, 1996, Tanzania Commission for 
AIDS (TACAIDS) et al., 2008). Zanzibar is now in the pre-elimination phase (WHO, 
2009). The success has been attributable to the cumulative high coverage in the 
implementation of ITN, IRS and IPTp. 
 
Malaria control strategies 
 
The National Malaria Control Programme (NMCP) through its second National 
Malaria Medium Term Strategic Plan (NMMTSP) seeks to reduce the burden of 
malaria by 80% between 2007 and 2013 (MoH&SW, 2007b). In order to achieve this, 
the NMCP adopted the WHO-recommended strategies. As regards to effective case 
management, the  NMCP plans to 1) increase coverage of malaria parasitological 
diagnosis through the introduction of RDTs where microscopes are unavailable; 2) 
increase access to ACTs through subsidy in the private sector; and: 3) improve the 
quality of care for severely ill patients; and 4) improve monitoring and evaluation. This 
thesis addresses the second strategy, that is, improvement of prompt access to ACTs (I), 
for those who get access, to determine factors influencing caretaker’s adherence to 
treatment (II). The thesis also addresses the third strategy, which is, improving quality 
of care for severely ill children at community level through the innovative strategy of 
pre-referral treatment with rectal artesunate followed by a referral to a health facility for 
definitive care (III, IV). 
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In the recent Tanzania Demographic Health Survey (TDHS), three-quarters of 
households in the Tanzania, Mainland owned some type of mosquito net. Household 
ownership of at least one ITN increased from 23 percent in 2004-05 to 64 percent in 
2010, and almost the same percentage of children under five slept under ITN the night 
before the survey. Approximately, one-third of the children under five had access to 
ACTs and prompt access was 26.7%. Compared to the Mainland, nearly 90% of 
household in Zanzibar owned a bed-net and about 80% owned ITNs. Since 2006, IRS 
coverage in Zanzibar has been over 95% compared to 4% in the Mainland (Tanzania 
Commission for AIDS (TACAIDS) et al., 2008). However, access to ACTs was 
considerably lower for children in Zanzibar (15%) and prompt access was only 4%. 
 
Funding of malaria control activities 
 
Tanzania depends on outside sources to finance malaria activities. The main funding 
agency is the GFATM, see Table 4. Concerns have been raised among development 
partners regarding the government budget allocation to malaria reduction from $5.2 
million in 2006-2007 to $2.8 million in 2007-2008 (USAID, 2009).  
 
Table 4: Major External Sources of Funding for Malaria Control Mainland  
(Source: President’s Malaria Initiative year five financial year 20101 Malaria 
Operational plan (MOP), Tanzania. November 13, 2009) 
Source Amount Period What is covered 
GFATM Round 4 54.2 Jun 05 – May 07 Provision of ACTs  
GFATM Round 7 52.5 2008 – 2013 -Improved malaria diagnosis using RDTs;  
-Access to ACTs in the private sector;  
-Improved quality of care in severe malaria; -
Monitoring and evaluation. 
GFATM RCC* 59.8 2008 – 2011 Support pregnant woman voucher; LLIN catch-
Up campaign for under fives; behaviour 
communication change; and monitoring and 
evaluation 
GFATM Round 8 113.3 2009 - 2014 Attain universal coverage of LLINs  
Strengthen regional malaria IMCI focal persons  
World Bank  25 Jul 07 – Dec 09 Under-five LLIN catch-up campaign  
Italian Cooperation 
2  
1.3 Jan 08 – Dec 09 Activities not yet determined.  
Swiss 
Development 
Corporation  
1.5 Sep 08 – Aug11 ITN Cell within NMCP  
Japanese 
International 
Cooperation 
Agency  
1 Jan 07 – Dec 09 Establishment of acute paediatric care units 
tertiary and regional hospitals 
*Global Fund – AIDS, Tuberculosis and Malaria - Rolling Continuation Channel 
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Malaria treatment policy in Tanzania 
 
Following Plasmodium falciparum resistance to SP three years after its introduction 
(Eriksen et al., 2005, Mubyazi and Gonzalez-Block, 2005), Tanzania changed the drug 
policy for treatment of uncomplicated malaria from SP to ALu in 2006 (MoH&SW, 
2006). However, the implementation of the policy change started in January 2007. The 
change was anticipated because of the increasing resistance from the time it was 
introduced (Mubyazi and Gonzalez-Block, 2005). Blood tests for malaria parasites are 
prepared in health centres and hospitals where microscopes and trained personnel are 
available. The NMCP is currently rolling out RDTs for malaria country-wide through 
the training of health workers at all levels, especially, at dispensary level. 
 
Antimalarial supply 
 
Government and PFNF health facilities provide ALu procured through MSD with 
funding support from GFATM. Tanzania has been invited to benefit from the AMFm, a 
strategy  introduced with the intent to reduce the cost of ALu at the manufacturer level 
so as to ensure availability of the drugs at an affordable price, in the private sector 
(Moon et al., 2009). 
 
1.9 EVIDENCE GAP AND RATIONALE FOR THE STUDIES 
Effective innovations exist supported with high level international commitment and 
financing (RBM-Partnership, 2008a). However, these efforts do not seem to 
commensurate with the slow pace towards attaining universal access to ACTs as 
evidenced by the low prompt access to ACTs, ranging between zero and 28% (Gitonga 
et al., 2008, Tipke et al., 2009, WHO, 2009). Studies are required to understand factors 
influencing the low uptake. In the absence of an alternative in the near future, the world 
community is facing a challenge to rapidly increase ACTs coverage while at the same 
time, preserve the drug effectiveness by avoiding irrational use, in order to avoid losing 
the few antimalarials to resistance. Studies on factors influencing prompt access to 
ACTs are necessary to inform policy decisions in the process of resolving this delicate 
balance. 
 
Most African countries adopted the ACTs between 2004 and 2006 (WHO, 2009). 
Thus experience of factors influencing adherence to ACTs treatment is mostly based on 
studies conducted in Asia (Gomes et al., 1998, Yeung and White, 2005), where the 
social and cultural context is different from Africa. Studies performed in Africa were 
mostly based on CQ (Agyepong et al., 2002, Ansah et al., 2001, Fogg et al., 2004), yet, 
ACTs are characteristically different from previous antimalarials in terms of access and 
its use. The few community-based studies performed on adherence to ACTs in Africa, 
have shown quite high adherence rates. This was contrary to the fear that dramatic 
cessation of symptoms due to high ACTs efficacy might prompt caretakers to 
discontinue treatment and save the remaining drugs for future use  (Hinton et al., 2007, 
Makanga et al., 2006). Studies in different contexts, such as in rural remote areas where 
the malaria burden is highest and access to recommended drugs is poor (Gitonga et al., 
2008, Tipke et al., 2009, WHO, 2009), are necessary to inform policy implementation. 
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Since 2006, the WHO recommended the use of pre-referral rectal artesunate 
suppository for children who could not take orally, followed by an immediate referral 
to a health facility (WHO, 2006). The policy recommendation is yet to be adopted by 
most member countries in Africa, including Tanzania, despite evidence of significant 
reduction in malaria mortality and central nervous system complications (Gomes et al., 
2008). A formative study reported the treatment modality was acceptable by members 
of the community (Warsame et al., 2007). Generating information on factors 
influencing caretakers’ decisions to adhere to referral advice after pre-referral rectal 
artesunate dose will, in addition to improving practice, add to information necessary to 
inform decision makers to expedite the adoption of this life saving strategy into the 
national malaria treatment policy guidelines. 
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2 AIMS AND OBJECTIVES 
Aim 
To study the factors influencing prompt access to effective antimalarials and adherence 
to treatment schedule as well as referral advice among children aged under five in rural 
areas in Tanzania. 
 
Specific objectives 
1. To determine the magnitude of, and identify factors influencing prompt access 
to ACTs among under five children in rural settings (I) 
2. To determine the degree of adherence to ALu treatment and its influencing 
factors in real life situations in under five children in a rural district (II). 
3. To determine the factors influencing parents’ decisions to adhere with advice 
to go to a health facility following pre-referral treatment (III) 
4. To understand caretakers’ decision making on whether or not to adhere to the 
referral advice after their child had been given pre-referral treatment with 
rectal artesunate, using qualitative methods (IV) 
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3 STUDY SETTINGS 
Studies I and II were conducted in Kilosa district while studies III and IV were 
conducted in Mtwara rural districts, see Figure 4.  
 
Kilosa district was selected for studies I and II because it is one among the highly 
malaria endemic districts in the country. The studies started 18 months since the 
commencement of the implementation of ACTs drug policy change in January 2007. 
While study (I) took four months to complete data collection, study II took 12 months 
(Figure 4). Data collection for study I and II started in Kilosa district, simultaneously, 
in June 2008. 
 
Mtwara rural district was selected for the studies because studies III and IV were nested 
on a rectal artesunate deployment study which started in 2004 (Figure 4). This enabled 
us to take advantage of the experience and rapport already created with the district 
authorities and the population at large. Study III was the first to start so as to minimise 
the recall period from the end of the deployment study to the present studies, followed 
by study IV a month after. 
 
Figure 4 showing study periods (I-IV) 
 
 
 
 
 
 
 
 
 
 
 
 
Kilosa district is one of the six districts in Morogoro region located about 300 km west 
of Dar es Salaam, the biggest business city in Tanzania, along the central railway to 
Kigoma and highway to Rwanda and Burundi (Figure 2). The district is bordered by 
Mvomero district in the south, Kilombero district in the west, Mpwapwa district in the 
north and Handeni district in the east. It has a population of about half a million people 
(Projections from the National Census, 2003) living in 260 villages (District Annual 
Report, 2008). About a third of the population lives below one dollar per day; a figure 
that includes both rural and urban areas, thus the poverty level is likely to be higher in 
the rural areas. There were 61 dispensaries, 7 health centres, 3 hospitals 152 drug shops 
of which 92 had been converted to ADDOs. Of these, Faith Based Organisation (FBO) 
owned nine dispensaries, one health centre and two hospitals. There were no private-for 
profit health facilities in the district. Malaria is one of the leading causes of out-patient 
attendance and admissions in the district accounting for more than half (55.5%) of the 
total outpatient attendance, and 60% of the total deaths among under-fives admitted 
to the hospitals (District Annual Report, 2008). Kilosa district reported the highest 
// 
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Rectal artesunate deployment study  
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percent of outpatient cases attributed to malaria in the country in 2008 (MoH&SW, 
2009a). 
 
Mtwara rural district is one among five districts in Mtwara region which is located 
south of Dar es Salaam (Figure 2). It is bordered by the Indian Ocean in the east, 
Mozambique in the south, Tandahimba district in the west and Lindi region in the 
north. The district has a population of about 212,000 and 112 villages. About one third 
of the population lives below the poverty line (District Council Annual Report, 2006). 
There were 30 dispensaries and four health centres and no hospital. Patients from 
dispensaries and health centres are referred directly to the regional hospital. During the 
deployment study, all 67 villages located 5 km or more from a nearby health facility 
were selected for the study; one health facility was built later. Malaria is also the 
leading cause of out-patient attendances and admissions in the district (MoH&SW, 
2008a) 
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4 MATERIAL AND METHODS 
 
4.1 STUDY DESIGN AND SAMPLE POPULATION 
A mixed methodological approach was used in this thesis with minimal interference on 
the day to day activities in the study areas in order to obtain data that reflected the real 
life situation as much as possible. This practical approach allowed addressing practical 
policy issues likely to act as a barrier to access ALu promptly and adhere to the 
treatment schedule as well as to referral advice. While quantitative methods were useful 
in determining the magnitude of the problem and its determinants, the qualitative 
method was employed in order to get a better understanding and the linkages between 
the various independent factors reported to influence the dependent variables studied in 
this thesis. Quantitative studies were started first based on the fact that the topics were 
generally known from studies previously performed on CQ and SP (Eriksen et al., 
2005, Nsimba et al., 2002).  
 
Rural villages were purposely selected because of the high malaria burden which is 
higher in these settings, prevalence of 20% compared to urban (7%) (Tanzania 
Commission for AIDS (TACAIDS) et al., 2008). In addition, caretakers in these 
settings are relatively poor compared to those in semi and urban settings (National-
Bureau-of-Statistics, 2002), thus, they are more prone to marginalization to access ALu 
(I) and health facilities (I and III).  
 
Studies in this thesis were community based, so as to obtain information from the end 
users of the services, a strategy that was more likely to gather information that reflects 
the real situation. In a setting where not all disease episodes are taken to a health 
facility, community-based studies are more likely to capture the views of the those who 
could not otherwise be reached (Marsh, 1998).  
 
Study I was prospective in nature in which under five children were followed up for six 
months. Those reported to have fever suspected to be malaria were recruited. The 
prospective method has the advantage of dealing with active cases hence minimising 
recalls period and bias (Kroeger, 1985). The method also has the advantage of 
establishing a time relationship between dependent and independent variables. The 
method is however limited by slow progress in recruiting cases when the event of 
interest occurs infrequently. In study I, it took 6 months to recruit the required number 
of children when the plan was to accomplish data collection within a period of four 
months. Study II was also prospective in nature. All children under the age of five, in 
five villages, were followed up at home and those found to have malaria, confirmed 
using RDT and treated with the correct dose of ALu, were enrolled, for a period of 12 
months.  
 
Study III was retrospective in design, nested in a rectal artesunate deployment 
intervention study (Gomes et al., 2008). A randomly selected number of under five 
children were followed up at home to determine factors likely to have influenced 
caretakers’ action, to adhere to referral advice or not, after pre-referral treatment with 
rectal artesunate. Retrospective study is the one in which the event of interest has 
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already occurred at the time of the study. In this approach, selection of subjects using 
random sample is easy, which allows making inference over the study population 
(Bowling, 2002). However, the method depends on recall which, in addition to 
reducing the quality of data, it is also likely to result in bias if there is a difference in 
recall between the groups being compared. 
 
Study IV was qualitative, conducted after study III to allow for preliminary analysis 
that gave an opportunity to develop relevant questions to make the interview guide 
focused. Focus group method was  employed, taking advantage of opening up 
discussions without personalizing opinions and also obtaining a community perspective 
on the issues discussed (Corell, 1995). 
 
4.2 SAMPLING AND SAMPLE SIZE 
Stratified sampling was performed in study I and II, in which, 161 rural villages were 
selected out of 260 villages in Kilosa district (National Census, 2003). Villages were 
grouped into four geographical climatic zones namely; wet-lowland, wet-highland, dry-
lowland and dry-highland. In study I, villages were grouped according to whether they 
had a health facility or not, for each of the four zones. Using EPI-Info software (version 
6; WHO, Geneva) one village was randomly selected from the group of villages with 
health facilities, and two, from villages without, making a total of 12 villages. Random 
sampling was performed to select the names of children under the age of five from an 
updated village register using the same software. Proportionate sampling of village’s 
size was used. In study II, villages in the wet-lowland area were purposively selected 
because of high malaria transmission throughout the year. Villages were grouped into 
those with and without a health facility, as in study I, and all children in the three 
villages (2,351) were followed up. Two semi-urban villages, headquarters of the three 
selected villages, were later added for the purpose of comparison, making a total of 
3,618 children followed-up. 
 
The deployment study, in which studies III and IV were nested, was aimed at testing 
the feasibility of community health workers and selected mothers to administer pre-
referral rectal artesunate to children who could not take orally, before referring them to 
a health facility. The study was conducted in 67 rural villages that were 5 km or more 
from a nearby health facility in which 2,281 were involved. Caretakers were followed 
up about two weeks later, to establish the action taken after the referral advice, and for 
those reporting to have gone to a health facility; information was confirmed using 
health facility records. In study III stratified sampling was performed in which all the 
children enrolled in the deployment study were grouped according to the action taken 
by caretaker after the pre-referral dose of rectal artesunate, that is, those who i) went to 
health facilities ii) went to drug shops iii) went to traditional healers and iv) took no 
further action.  
 
Sample sizes for studies I-III were calculated using the formula for independent 
observations assuming a maximum length of a 95% confidence interval to be +/- 5%. 
In study I and III, the assumed proportion of 50% was used due to large variations 
reported in literature and in study III acceptance of referral from the deployment study 
was not yet known. In study II, the proportion of caretakers adhering to treatment was 
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assumed to be 24% (Nsungwa-Sabiiti et al., 2005). Finally, adding 10% for possible 
loss to follow-up and appropriate correction factor for clustering effect (ICC=0.01). 
In study I, the sample size came to 591 (approximated as 600). Assuming the incidence 
of  6% in two weeks (Hetzel et al., 2008), 1,200 children were followed-up in order to 
obtain the sample size in four months. However, it took six months to obtain the 
required number and 35 children dropped out and were replaced using random 
selection method. In study II, the sample size was 399 (approximated as 400). 
Assumption was made that 80% of the febrile children will be attended at a health 
facility (de Savigny et al., 2004), thus the study was planned to take four months. But it 
took 12 months to recruit the required number of children, because, during data 
collection many children in the remote villages were reported to be treated by drug 
vendors. In study III, the sample size was 800, thus the aim was to have 200 children 
from each of the four strata. However only those who went to a health facility had more 
than 200. Therefore 286 children were randomly selected from those taken to health 
facilities (in total 1810) and all children who went to a traditional healer (in total 52), 
drug shops (in total 202) and took no further action (in total 201). 
 
In the qualitative study (IV), focus group discussions (FGDs) were conducted in three 
villages. The decision on the number was determined by saturation and geographical 
representation. When selecting the next village priority was given to a different 
geographical area, that is, coastal and inland areas. One FGD was conducted per day in 
order to allow time for reflection. In each village, FGDs were held with a male and a 
female group of caretakers, separately; whose children had pre-referral treatment and 
those who did not, making a total of four FGDs in each village, adding up to 12 FGDs. 
Female and male group discussions were performed to give an opportunity to each 
group to express themselves freely. The caretaker at the time the child was sick was 
invited in the treated groups, with the support from CHWs who knew them. Each FGD 
comprised of 6-10 participants. Selection was made to represent people of different 
social characteristics. A total of 84 participants were involved with a male to female 
ratio 1:1. Participants were small scale farmers, half of them with primary level 
education.  
 
4.3 DATA COLLECTION METHODS 
Research assistants (RA) for study I were CHWs in the respective villages, supervised 
by members of the research team recruited from the research group, working at the 
study site in Kilosa, and the Principal Investigator (PI). In study II research assistants 
experienced in blood sampling from children were recruited. RAs were initially trained 
by the principal investigator on questionnaire administration and by a pharmacology 
technician in blood sampling. They were then involved in a pilot study that aimed at 
refining data collection instruments and giving them practical exposure to taking blood 
samples and data collection. In study III research assistants were form six leavers also 
working at one of the research sites in Mtwara district. These were supervised by a 
member of the research team, and the PI.  
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Structured interviews 
 
Structured interviews have the advantage of being easy to conduct and to obtain data 
hence they are a commonly used technique in health systems research where data are 
often required to  feed on implementation policy/ programme (Varkevisser et al., 1991).  
However, the method is limited by the subjectivity of responses especially when the 
topic in question is sensitive. The method also limits detailed explanation of an event.  
Structured interviews were conducted in studies I-III. A questionnaire was prepared 
based on literature review and pilot tested to validate the questions. Face-to-face 
interviews were held with the caretakers at their homes to obtain socio-economic and 
demographic data, knowledge about malaria and other variables thought to influence 
the outcome variables. Interviews were conducted in Kiswahili, the language spoken by 
the majority of Tanzanians, about one week from the time of the event in study I and II. 
In study III and IV, the recall period was longer, between 3 months and 3 years. 
 
Direct observation  
 
Observation of events has the advantage of capturing first hand information on an 
ongoing event hence no recall is involved (Robson, 2003). However, the method is 
limited by the risk of the person under observation altering behaviour so as to conform 
to what is desirable (Hawthorn effect). In study III, community drug dispensers 
observed child symptoms and recorded them on a form before administering the initial 
dose and referring the caretaker to a health facility using a referral form. Adherence to 
referral advice was confirmed by checking records at the respective health facilities 
where the caretaker had reported to have taken the child.  
 
Laboratory methods 
 
Laboratory methods produce more reliable findings compared to self reporting; 
however, the method is only available for some types of studies and often expensive. In 
study II, blood samples were collected to determine lumefantrine concentration levels 
using a field adapted method  (Ntale et al., 2008). The use of filter paper method 
ensured that a small amount of blood was taken and easily handled during 
transportation with no need of refrigeration. This method is thus well adapted in 
tropical settings (Bergqvist et al., 1987). High Pressure Liquid Chromatography was 
used to measure blood lumefantrine concentration as described by Ntale et al (Ntale et 
al., 2008). 
 
Focus group discussions 
 
FGD is a method for collecting data in qualitative studies. The method has the 
advantage of allowing participants to share ideas in responding to research questions 
(Cresswell, 2007). The method works well if the research topic is not sensitive. The 
disadvantage of the method is that social norms might not allow some people to 
contribute effectively in the discussion and it requires a good moderator to guide and 
obtain relevant information from participants (Cresswell, 2007). FGDs were performed 
in study IV where detailed information was collected on factors influencing adherence 
to referral advice and how the factors interrelated to each other.  The main questions 
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were pre-tested in one village and the interview guide modified. Discussions were held 
in a quiet place or village government office after participants had signed a written 
consent form. Discussions were moderated by a Tanzanian male social scientist and 
took about one and a half hours. The moderator was assisted by two male research 
assistants, one took notes and another made observations. Discussions were conducted 
in Kiswahili and were tape-recorded.  
 
Triangulation 
 
Triangulation means the use of one or more methods with the purpose to cross-check 
data credibility/validity in a study (Cresswell, 2007). There are several types of 
triangulation (Todd, 1979), these include method triangulation the use of different 
methods to study the same objective/phenomenon. This was achieved in study III and 
IV where the objective in both studies was to establish factors influencing adherence to 
referral advice using quantitative methods in study III and qualitative in study IV. Data 
triangulation, where a different type of data is collected to answer the same question 
was performed in study IV where the same questions were asked to male and female 
caretakers whose children had pre-referral treatment and those who did not. The 
experience of caretakers whose children had pre-referral treatment was triangulated 
with those whose children were not treated. The caretakers of non-treated children were 
taken as independent observers, as relatives or neighbours of a treated child, in a rural 
community where people interact closely. Investigators’ triangulation where multiple 
researchers of different disciplines interpret the same data was achieved in study IV 
through the participation of a social scientist, health systems and malaria researchers, 
some with local and other with international experience. Other methods include 
theoretical triangulation where more than one theoretical framework is used to 
interpret a phenomenon.  
 
4.4 DATA ANALYSIS 
Quantitative data was double entered and validated using – EpiData software (EpiData 
Association, Odense, Denmark) and analysed using Stata version 10 software (Stata 
Corp., College Station, TX, USA). The unit of analysis was individual child in studies 
I-III. In order to avoid overrepresentation by those with more episodes, only first 
episode was taken for analysis in study I and II. The primary outcome variable for 
study I was prompt access to ALu, and the secondary was source of care. No child 
received ALu more than once in one episode, this avoided confusion in classifying 
children in the outcome variable. History of fever was used as diagnosis for 
presumptive malaria, as this was the recommended definition of malaria at the time the 
studies were conducted (MoH&SW, 2006, WHO, 2006)  and had been used in several 
other studies (Gitonga et al., 2008, Malenga et al., 2005, Tipke et al., 2009). Weighted 
analysis over the strata was used to obtain unbiased estimates. In study II, the outcome 
variable was, reported adherence to ALu treatment. Caretaker’s report was used as the 
basis for defining adherence to treatment (see definitions). Analysis of blood 
lumefantrine concentrations by explanatory variable was limited by the lack of a clear 
cut-off point. In study III, the outcome variable was adherence to referral advice 
defined as action taken by caretakers following pre-referral treatment with rectal 
artesunate. Those who went to health facilities were regarded as adherent and this 
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information was verified at the respective facilities. Analysis included data collected at 
the time the child was sick and merged with those collected in study III. Both pooled 
analysis and analysis by strata were performed after finding significant differences 
between strata on the outcome variable 
  
Measurements 
 
Descriptive statistics were presented as means, median and proportion in studies I-III. 
Contingency tables were made and analysed using Chi square test. P values of 5% were 
taken as the cut-off point for significance testing. Logistic regression analysis was 
performed in studies I-III. Explanatory variables likely to influence outcome variables, 
and had no values of more than 90% in one attribute were introduced in a stepwise 
(manual) regression analysis using a 10% cut-off point for the p-values to obtain a 
parsimonious model. 
 
Wealth status calculation using Principal Component Analysis (PCA) 
Wealth index was calculated using principal component analysis (PCA). The method is 
useful in situations where income data is difficult to obtain (Filmer and Pritchett, 2001). 
The method applies the concept of using the first principal component that contains the 
most important aspect of data in terms of variance.  Using 19 household assets adopted 
from the TDHS 2004/5, PCA was performed by introducing variables that had no 
attribute with more than 90% subjects. Each asset was assigned a weight loading by 
scoring with the first principal component before dividing wealth status into quintiles. 
Quintiles were then grouped into better-off (quintile 3-5) and poor (quintile 1 and 2) 
  
Qualitative - Qualitative content analysis was conducted in study IV. Transcription of 
tape recorded information was performed together with the notes taken during FGDs 
and were translated back into English. Latent qualitative content analysis (Graneheim 
and Lundman, 2004) taking advantage of its ability to take into consideration variations 
in opinions among participants was performed. Manual analysis was conducted by 
coding the information and assigning categories. While the main author initiated the 
coding and category assignments, others went through them identifying areas of 
discrepancies and discussions were held until consensus was reached. Comparison was 
made between codes and between categories (Graneheim and Lundman, 2004). 
Comparisons were also made between treated and non-treated; and male and female 
groups and little difference was found. The unit of analysis was a group and not 
individuals; this was performed in order to retain the context of the FGD. Relevant 
statements were extracted and presented verbatim. Preliminary results were discussed 
in a researchers’ forum where critical comments were obtained and addressed. 
 
4.5 ETHICAL CONSIDERATIONS AND CLEARANCE 
Ethical concern in study I, III and IV was in the use of participants’ time when they 
could be doing other personal productive work. However, participation in the research 
had a benefit to a larger community thus outweighing personal loss of time or 
inconvenience. A minimum number of questions were asked, necessary to answer the 
objectives, in order to maximise the use of time. The topics raised during the interviews 
were not sensitive and were thus less likely to interfere with or disturb the caretakers’ 
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personal emotions. Confidentiality was another issue likely to be of concern. This was 
ensured by using code numbers instead of names to identify children and blood 
samples. Only the principal investigator had the key to the codes. Study II, involved 
blood sampling; where a drop of 100 µL was obtained through a finger prick after 
caretakers’ consent. A total of 18 caretakers refused to take blood samples from their 
children and were excluded. Blood samples drawn from children cause pain and have a 
risk of cross-infection if not properly performed. Special paediatric prickers were used, 
that in addition to minimizing pain, ensured an optimum drop of blood was obtained. 
Research assistants wore plastic gloves and cleaned the site with spirit to prevent cross-
infection. The blood drop was spotted on a filter paper and dried before storage in 
plastic envelops, thus further minimising cross-infection. 
 
Informed consent was administered to caretakers in Kiswahili, a language spoken by 
most Tanzanians. Caretakers signed a written informed consent form on behalf of their 
children. Those who did not know how to read and write, the information was read in 
the presence of a witness and then thumb-printed and the witness countersigned. 
Caretakers were made aware of their freedom to refuse entering in the studies (I-IV) as 
well as withdrawing, in the course of the studies, without negative consequences. 
Although some caretakers required additional information prior to signing, there was no 
refusal. Ethical approval, for all the studies (I-IV), was obtained from the Muhimbili 
University College of Health Science. Permission to conduct studies was obtained from 
the relevant authorities at the regional, district and village level before commencing 
data collection.  
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4.6 SUMMARY OF METHODS 
 
Sub-
study 
Objectives Subjects and 
sample size 
Design and 
Method 
Analysis Year of field 
work 
I To determine the 
magnitude of, and 
identify factors 
influencing prompt 
access to ACTs among 
under five children in 
rural settings 
600 under 
fives 
reported to 
have fever 
Follow up 
study using 
structured 
questionnaire  
interviews 
Descriptive, 
multiple 
logistic 
regression  
2008 
II To determine the degree 
of adherence to ALu 
treatment and its 
influencing factors in 
real life situations in 
under five children in a 
rural district. 
 
 
400 Under 
fives 
diagnosed to 
have 
malaria 
using RDT 
and treated 
with 
artemether-
lumefantrine 
 
Follow up 
study using 
structured 
questionnaire  
interviews 
and blood 
sample taken 
for 
lumefantrine 
concentration 
Descriptive, 
multiple 
logistic 
regression 
2008-2009 
III To determine the 
factors influencing 
parents’ decisions to 
adhere with advice to 
go to a health facility 
following pre-referral 
treatment  
 
587 under 
fives treated 
with rectal 
artesunate 
Retrospective 
study nested 
in an 
intervention 
study. 
Caretaker of 
children 
followed up at 
home and 
interviewed  
using 
structured 
questionnaire   
Descriptive, 
multiple 
logistic 
regression  
2007 
IV To understand 
caretakers’ decision 
making on whether or 
not to adhere to the 
referral advice after 
their child had been 
given pre-referral 
treatment with rectal 
artesunate, using 
qualitative method  
12 Focus 
group 
discussions 
Qualitative 
study, nested 
in an 
intervention 
study using 
FGDs 
Qualitative 
content 
analysis 
2007 
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5 RESULTS 
5.1 PROMPT ACCESS TO ARTEMETHER-LUMEFANTRINE (I) 
A total of 1,200 children were followed up for a period of six months and 35 of them 
were replaced because of attaining the age of five or shifting residence, making the total 
number of children followed 1,235. In total 957 episodes of fever were recorded of 
which 607 were first episodes, these were used as the basis of the analysis. 
 
Table 5 shows that, less than half of the febrile children were taken to government 
facilities. Those who were taken elsewhere, nearly half of them (44.6%; 153/343) went 
to ordinary shops and only a third were taken to FBO facilities and ADDOs; which was 
less that 20% of all the children (114/607).  
 
Table 5: General information on type of care sought and received by caretakers  
Source of care Number Percent 
Children who received care from government 
facilities 
264/607 44.8* 
Children who received care from ordinary shops 153/343 44.6 
Children who received care from FBO facilities 
and ADDOs 
114/343 33.2 
Access to artemether-lumefantrine Number Percent 
Children treated with any antimalarials  374/607 66.3* 
Children treated with ALu  268/607 45.8* 
Children treated with ALu at government facilities  220/264 83.3 
Children treated with ALu at FBO and ADDOs 41/114 37.0. 
Prompt access to artemether-lumefantrine Number Percent 
Children who had prompt access to ALu  223/607 37.6* 
Children who had prompt access to ALu in 
government facilities 
185/264 70.1 
Children who had prompt access to ALu in FBO 
facilities 
27/86 31.4 
Children who had prompt access to ALu in 
ADDOs 
6/28 21.4 
* Weighted data - weighted analysis over the strata was used to obtain unbiased 
estimates. Analysis within sub-samples was not weighted. 
 
Two-thirds (66.3%) of the children were treated with any antimalarial while nearly half 
(45.8%) of all children were treated with ALu.  The majority (>80%) of the children 
treated with ALu were those taken to government facilities. Despite having subsidized 
ALu, FBO facilities and ADDO contributed less than 10%% (41/607) of the children 
who accessed the drug. Approximately, one third of the febrile children had prompt 
access to ALu; which was higher in government facilities (70%) compared to FBO 
facilities and ADDOs where less than one-third had prompt access. 
 
Caretakers who sought care from FBO facilities reported paying for drugs more 
(median expenditure Tsh 2,500) compared to other sources of care; followed by 
ADDOs (median expenditure Tsh. 1,600). About 10% (26/264) of caretakers who 
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sought care from government facilities reported paying for drugs (median expenditure –
zero). The median expenditure on drugs was higher among the poor (median 
expenditure Tsh. 500) compared to the better-offs (median expenditure - Zero). 
 
Table 6 shows that children whose caretakers sought care from government facilities 
were 17-times more likely to have prompt access to ALu compared to those taken 
elsewhere. Lack of prompt access was highly attributed to not getting ALu (>80%). 
The median distance to the government facility was shorter (2 km) for children who 
had prompt access to ALu compared to those who did not (5 km). Caretakers from 
better-off household and those who had knowledge on the recommended treatment for 
uncomplicated malaria were 2-3 times more likely to access government facilities than 
the poor and those without knowledge.  
 
Table 6: Determinants of prompt access to artemether-lumefantrine and accessing 
care from government health facilities for children under five  
 Unadjusted OR Adjusted OR 
Factors influencing prompt access to 
ALu in all  strata  n= 607 
OR  95% CI OR  95% CI 
Children whose caretakers sought care at 
government health facility 
17.7   10.55 - 29.54 16.87 10.06-28.28 
Children from better-offs households 
(Quintile 3+) 
2.1    1.39 - 3.28   
Children whose caretakers knew that 
dawa mseto (ALu) is the recommended 
drug for the treatment of malaria ya 
kawaida (uncomplicated malaria) 
2.04   1.36 - 3.07 1.26 0.76-2.09 
Factors influencing seeking care from 
government health facilities in all  strata  
n=607 
    
Children from better-offs households 
(Quintile 3+) 
3.22 2.10 - 4.92 2.56 1.63-4.01 
Children whose caretakers knew that 
dawa mseto (ALu) is the recommended 
drug for the treatment of malaria ya 
kawaida (uncomplicated malaria) 
2.55 1.71 - 3.81 2.07 1.35-3.16 
 
Caretakers from the better-off households were found to live closer to government 
facilities (average 2 km) compared to the poor (average 5 km). The better-offs were 4-
times more knowledgeable about the recommended treatment for uncomplicated 
malaria than the poor and were approximately 3-times more likely to own a radio.  
 
5.2 ADHERENCE TO ARTEMETHER-LUMEFANTRINE TREATMENT (II) 
A total of 544 eligible children were identified at the health facilities, of which, 467 
(85.8%) were traced at home on day 7. Loss to follow up was attributed mainly to the 
caretaker not being at home on the day of the visit. Repeat follow up on the next day 
could not be performed because the visits were specifically targeted for day 7. The 
relatively high follow up rate was due to the low numbers of children followed-up per 
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day (0-3). With the use of a motorcycle, RAs could trace caretakers who were not at 
home but within a reachable distance, up to 10 km. Blood samples could not be 
collected from 21 children because caretakers refused (18) or RA failed to draw blood 
(3); and two caretakers could not remember the details on drug administration. Thus, 
complete data was available for 444 children.  
 
Of the 444 children, 392 (88.3%) were reported by caretakers to have received ALu 
according to the recommended schedule. Non-adherence was attributed mainly to off-
schedule dosing (untimely) rather than missing doses. Non-adherence was higher with 
the last dose, as indicated by a drop in the reported adherence (Figure 5). 
 
Figure 5: Bar chart showing percent adherence as reported by caretakers for each 
dose and cumulative adherence from dose 1 to 6 (n=444)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The odds for children from better-off households to adhere to ALu treatment was 2-
times larger compared to the poor, after adjusting for confounding factors (OR 2.45; 
95% CI 1.35-4.45; adjusted OR 2.23; 95% CI 1.20-4.13). While more than 90% of the 
caretakers reported correct knowledge about the frequency and duration of 
administration of the drug, basic primary level education was not found to influence the 
reported adherence to treatment schedule. 
 
No significant difference in mean blood lumefantrine concentrations was found 
between children whose caretakers reported adherence and non-adherence, 
respectively. The corresponding median levels were 286 nmol/L and 261 nmol/L 
(Figure 6). There was however a wide variation in blood lumefantrine concentration 
ranging from 25 nmol/L, which was the limit of quantification, to 9,318 nmol/L for the 
total group, and 25 nmol/L to 1382 nmol/L for those with reported non-adherence and 
25 nmol/L to 9318 nmol/L for those with reported adherence. Extreme values (outliers) 
are not shown in Figure 6. 
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Figure 6: The distribution of lumefantrine blood concentration levels of study 
children by reported adherence status (n=444). Outliers not shown in box-plot. 
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5.3 ADHERENCE TO REFERRAL ADVICE (III)  
A total of 757 children were traced at home, of these, 588 (78%) were found and their 
caretakers interviewed. The loss to follow up was attributed mainly to shifting place of 
residence or not found at home after three follow up visits as shown in Figure 7. One of 
the children excluded from the analysis was found to have not met the criteria for 
inclusion; hence, analysis was based on 587 children. Loss to follow up was higher 
among those who went to traditional healers (38.5%) compared to other groups (19-
23%).  
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Figure 7: Flowchart: The number of children whose caretakers were 
traced and interviewed and those not traced 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nearly a third of the children (31%; 182/587) had altered consciousness and / or 
convulsions at the time of pre-referral treatment; and the majority were taken to the 
health facility (56.4%; 102/181) compared to those taken to traditional healers (7.2%; 
13/181).  
 
Table 7 shows the results from pooled analysis of action taken after pre-referral 
treatment with rectal artesunate (see analysis section). Children with altered 
consciousness and or convulsion (severe symptoms) were 3 -times more likely to 
adhere to referral advice compared to those with less severe symptoms (OR 3.47, 95% 
CI 2.52–5.17, P < 0.0001). Further analysis by strata showed varying odds ratio 
between health facilities-traditional healers comparison (OR 1.53; CI 0.73–3.19) and 
health facilities- no action comparison (OR 4.0 2.43–6.60). Over 90% of the caretakers 
reported to have been told to go to a health facility after the pre-referral dose of rectal 
artesunate. Those reporting knowledge on when and why they should have gone to a 
health facility were twice more likely to adhere than those who did not, OR 2.19, 95% 
CI 1.48–3.23  and OR 1.77, 95% CI 1.07–2.95, respectively.  
 
588 children whose 
families were successfully 
interviewed 
587 children and their 
caretakers included in the 
analysis 
 
169 children not                 
found 
96 migrated 
71 not found 
2 died 
 
757 treated children  
Parent of a treated child who 
should not have been treated 
and referred was excluded 
from analysis  
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Table 7: Factors affecting adherence to referral advice after pre-referral dose of 
rectal artesunate, with adjusted odds ratio (OR) from logistical regression 
analysis, (n=587) 
 
About 21% (124/587) of the caretaker reported paying at the health facilities, of these, 
the majority (79%; 98/124) resided in villages served by a PNFP facility. A small 
proportion (5.5%; 26/445) of the caretakers residing in villages served by government 
facilities reported paying for services. Caretakers residing in a catchment area of 
facilities that charged for services and reported paying for laboratory and consultation 
services were 4-5 times less likely to adhere to referral advice, Table 8. In this area, 
severity of symptoms did not influence adherence to referral advice.  
 
Table 8: Factors influencing adherence to referral advice in government and non-
government catchment areas 
Government health facilities catchment villages OR 95% CI P-value 
Children presenting with altered consciousness and 
convulsion 
3.90 2.35-6.45 0.000 
Children whose caretakers paid for consultation 0.86 0.36-2.09 0.744 
Children whose caretakers paid for drugs 1.10 0.70-1.74 0.680 
Children whose caretakers paid for laboratory tests  2.36 0.28-19.81 0.430 
Faith-based health facilities catchment villages    
Children presenting with altered consciousness and 
convulsion 
1.05 0.39-2.87 0.92 
Children whose caretakers paid for consultation 0.13 0.02-0.73 0.021 
Children whose caretakers paid for drugs 6.48 1.48-28.32 0.013 
Children whose caretakers paid for laboratory tests  0.17 0.04-0.73 0.018 
 
Although charges for services at NGO facility deterred adherence to referral advice, 
SES was found to have no influence. The distance to and the perceived quality of care 
at the health facility as well as caretaker’s basic education did not influence adherence 
to referral advice in all settings. 
 
 
Seeking care from health facility vs. all other 
actions (pooled results) OR 95% CI P-value 
Children presenting with altered 
consciousness or convulsion 
3.26 2.24-4.74 0.000 
Children whose caretaker had 
knowledge about cause of malaria 
0.52 0.36-0.76 0.001 
Children whose caretaker reported 
being advised on when to go to a health 
facility 
2.21 1.53-3.18 0.000 
Children whose caretaker reported 
being advised on why should go to a 
health facility 
1.66 1.02-2.68 0.040 
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5.4 ADHERENCE TO REFERRAL ADVICE (IV) 
Caretakers’ decisions to referral adherence or not, after pre-referral treatment with 
rectal artesunate dose, fell under four groups. There were:- 
Caretakers whose child condition improved and they did not proceed to a health 
facility.  
 
‘Just after doing the suppository insertion the fever went down. So we decided not to go 
to the dispensary (Male participant of a child treated with rectal 
artesunate) 
 
There were caretakers whose child condition improved and they adhered to referral 
advice but without clearly understanding the rationale for doing so.  
 
‘… because when a child gets high fever, you will hear the mother saying  next morning 
'today I am just going to the hospital, but with that medicine they inserted into my child 
it helped him/her. So I am going just for the sake of it'. (Female participant of a child 
not treated with rectal artesunate) 
 
There were those caretakers whose child’s condition improved and they adhered to 
referral advice with a clear understanding of the reasons.  
 
‘… … now you see it is better to go to the hospital and see the doctor because he uses 
medical equipment…he can examine him and tell how many malaria parasites the child 
has’ (Female participant of a child not treated with rectal artesunate). 
 
The last group was of caretakers whose child condition did not improve and they 
mostly reported to adhere to referral advice.  
 
‘After inserting the drug degedege (convulsions) and quivering stopped but I still went 
to the health facility because the child was still sick’ (Female participant of a child 
treated with rectal artesunate) 
 
The different standpoints were a result of misunderstanding the information about when 
to go to a health facility, and why, as reported by different participants in the FGDs. 
 
Caretakers' whose children had pre-referral treatment with rectal artesunate, especially 
those whose child condition improved, were faced with a dilemma to decide on 
whether or not to adhere to referral advice.  In decision making, caretakers seemed to 
weigh the condition of the child after pre-referral treatment, against other competing 
priorities, difficulties in reaching the health facility and perceived quality of care. Some 
of the obstacles met at the health facilities included a few staff, negative attitude of 
providers to the caretakers, drug shortages and informal payments. When the child 
condition did not improve, caretakers would tend to adhere to referral advice 
irrespective of these constraints. But these constraints become a concern to adherence if 
the child condition is seen to have improved  
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"Going to the health facility does not-need transport costs. One can walk even to 
town (30 km) if he/she has a sick child". (Male participant of a child not treated with 
rectal artesunate) 
 
There was also a gender perspective on adherence to referral advice where male parents 
reported to be involved when the child condition was critical, or money was needed or 
when care-seeking required travelling far away or during the night. 
  
‘ … We (male parents) contribute a lot to this problem. We have a lot of other plans 
and activities. It is only when the condition has become critical that is when we act …  
So after having the first aid (suppository treatment) the father would say, 'but the kid is 
playing now! Why don’t I go and do my things. Meanwhile, the child’s condition might 
be getting worse (Male participant of a child treated with rectal artesunate) 
 
This was confirmed by female participants who reported that, in general, the 
responsibility for seeking care rests upon them when the child’s condition is perceived 
as not being life threatening.   
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6 DISCUSSION 
Caretakers with children who had altered consciousness and convulsions were 4-times 
more likely to adhere to referral advice than those with less severe symptoms, such as 
lethargy, failure to feed and vomiting (III). Caretakers whose children did not improve 
after the initial pre-referral dose were also more likely to adhere to referral advice than 
those who improved (IV). In addition, the caretakers’ practice of taking children with 
convulsion to health facilities was quite high (III) contrary to previous reports where 
they were taken to traditional healers (Makemba et al., 1996, Winch et al., 1996). 
Rectal artesunate has been reported to significantly reduce malaria mortality and central 
nervous system complications in African settings (Gomes et al., 2008) and that the 
rectal application was acceptable to community members (Warsame et al., 2007). The 
WHO recommended its use for children with malaria who were unable to take oral 
medication, followed by referral where treatment was not available, since 2006. Studies 
III and IV were nested in the rectal artesunate deployment study; these thus contribute 
some knowledge in the information gap necessary to inform policy decisions for the 
adoption and implementation of this life saving strategy. 
 
This thesis has shown that once a child had access to ALu, caretakers were likely to adhere to 
treatment schedule (II); and to referral advice, if child had severe symptoms or not improved 
after pre-referral treatment (III, IV). This conforms to the pre-referral rectal artesunate 
strategy that aims at reducing deaths resulting from severe malaria. These finding 
suggests that strategies to increase the low prompt access found in study I should be of 
high priority. Moreover, a wide coverage in prompt access to ALu will reduce the need 
for rectal artesunate strategy (Gomes et al., 2008). The few studies conducted before 
policy change to ACT  (Krause and Sauerborn, 2000, Nsungwa-Sabiiti et al., 2005) that 
addressed most of the steps in the pathway to survival, reported weaknesses in almost 
all the stages (Claeson and Waldman, 2000). Lower levels of prompt access to ALu, 
compared to findings in study I, have been reported in several African countries 
(Gitonga et al., 2008, Tipke et al., 2009, WHO, 2009). An important question addressed 
in the following discussion is, why there was low prompt access to ALu in rural remote 
areas, where the malaria burden is known to be high, when there is a high level of 
political commitment with pro-poor policies, and huge financing at national and 
international levels?  
 
Studies in this thesis were conducted from a caretakers’ perspective, thus shedding 
more light on the immediate and some of the underlying factors influencing access to 
ALu, as well as health facilities, for those who were referred. Thus, further analysis on 
the underlying factors likely to influence the outcomes (UNICEF, 1998) was performed 
using the existing data from literature in order to enrich the discussion.  
 
6.1 PROMPT ACCESS TO EFFECTIVE MALARIA TREATMENT 
6.1.1 Prompt access to treatment in governmental facilities  
The immediate factor influencing the low prompt access to ALu was, overwhelmingly, 
the source of care (I); where, caretakers seeking care from government facilities were 
about 17-times more likely to have prompt access, compared to those who went 
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elsewhere (I). However, less than half went to government facilities where prompt 
access to ALu was found to be high (I). Not receiving the recommended drug was the 
main contributing factor (>80%) to lack of prompt access (I). Studies on factors 
influencing access to antimalarials in Africa are mostly based on previous antimalarials, 
that is, CQ and SP (Chuma et al., 2009, Holtz et al., 2003, Kazembe et al., 2007, 
Nsungwa-Sabiiti et al., 2004, Rutebemberwa et al., 2009a). In these studies, most of the 
factors found in studies I and IV were reported. However, the finding in study I, that the 
source of care was the only factor influencing prompt access to ALu after controlling 
for confounders, was new. The underlying reasons for accessing government facilities 
were distance to government facility, SES and knowledge of malaria treatment. Half of 
the caretakers who had prompt access to ACT resided within 2 km from government 
facilities compared to those who did not (median 5 km). In study IV, caretakers 
reported to be deterred to adhere to referral advice by the informal payments, poor 
provider-caretaker interaction, characterized by negative attitudes to caretakers by some 
of the health workers, and drug shortages in government facilities. Similar findings 
have been reported to influence access to government facilities in previous studies 
(Goodman et al., 2009, Rutebemberwa et al., 2009c). However, in study I, drug 
shortages were uncommon due to the vertical logistic supply of ALu that allows such 
programmes to by-pass the routine logistic system (MoH&SW, 2007a). In addition, the 
international support through the MMSS ensures adequate availability of the drug in the 
country  (Roll-Back-Malaria-Partnership, 2005). 
 
In order to further understand the underlying reasons, there is a need to answer the 
pertinent question, why caretakers did not seek care from government facilities, where 
services are supposed to be free? In study IV, caretakers raised concerns on the few 
numbers of health workers at health facilities in which one facility could be served by 
only one clinical officer for a catchment of 4-5 villages, each having between 3,000 and 
5,000 people (IV). Inadequate provider performance has been reported to be associated 
with high workload, due to severe staff shortages, unskilled staff, lack of motivation 
and support supervision from the district  (MoH&SW, 2007a, MoH&SW, 2009a). In 
Tanzania, like in many other African countries, human resources for health are in a 
crisis and threaten efforts to reach the MDG goals (Gerein et al., 2006, Jong-wook, 
2003a, Narasimhan et al., 2004, Riley et al., 2005). With a staffing gap of over 60% 
(MoH&SW, 2009a), providers lack adequate time to communicate effectively to 
caretakers (Riley et al., 2005). The problem is experienced more in rural facilities, due 
to poor communication, infrastructure and social amenities and lack of opportunities for 
extra income from private practice or attending workshops; making the attrition rate in 
these settings higher (Riley et al., 2005). In one of the study facilities (II), a trained 
nurse was observed to prescribe, dispense, provide antenatal and child health care as 
well as mobile services to neighbouring villages, during the whole year of study period. 
 
Health workers in rural remote areas also lack regular supportive supervision from the 
district managers  (MoH&SW, 2009a). Where supervision occurs, the quality of 
supervision is inadequate, partly due to the criteria of measuring supervisor 
performance through number of visits instead of outputs (MoH&SW, 2004). Incentives 
for performance improvement are lacking and salaries are meagre thus hampering 
performance (Manongi et al., 2006). Salaries for health workers in Tanzania are no 
different from other African countries ranging between 70 – 300 USD per month 
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(Buchan and Sochalski, 2004, Friedman, 2004); the lowest being among rural health 
staff (Gerein et al., 2006, McCoy et al., 2008).  Thus, a health worker with an average 
family of 6 dependents (National-Bureau-of-Statistics, 2010) will have an income less 
than the poverty line of 1.25 USD per person. Since their income does not correspond 
to the cost of living, most health workers utilise their working hours to earn a living 
through other income generating activities such as seminars and workshops (Roenen et 
al., 1997, Rowe et al., 2005) while others resort to soliciting informal payments (IV). 
Improvement in salaries and incentives is made difficult by the low countries GDP per 
capita (Schiavo–Campo et al., 1997). In addition, because there is no link to 
performance, due to inadequate supervision and routine health information system, 
increase in payment might not necessarily lead to improved health services  
(MoH&SW, 2004, Simba and Mwangu, 2005). Efforts by international agencies to 
improve country health systems through the Health Metric Network (WHO, 2010b) are 
yet to reach the caretaker-providers level  As a result of the huge workload and low 
pay, staff does not have enough time and motivation to offer user friendly services. In 
this context, the performance of the provider is driven by a personal sense of duty, 
more than the checks-and-balances that should be inbuilt within the system. 
 
6.1.2 Prompt access to treatment in formal private drug outlets 
Study I showed that faith-based organisations (FBO) facilities charged caretakers a 
relatively higher cost for drugs compared to other facilities. These fees deterred 
caretakers from adhering to referral advice (III). It also undermined the advantages that 
FBO facilities have in being located in rural remote areas where organisations that 
serve the vulnerable and poor are required. The fees are defended as being necessary in 
order for the FBOs to meet operational costs (Njau et al., 2006). Although the 
government gives grants to designated hospitals and subsidies to some FBO hospitals, 
this arrangement leaves out FBO health centres and dispensaries (MoH&SW 2009),   
 
The national policy is to provide free medical services to children. But those residing in 
areas served by FBO facilities do not always benefit. Although the new HSSP III 
recommends that local governments contract out services to the private sector, 
especially where government services are not available or inadequate, these policies 
have yet to be implemented (MoH&SW, 2009a).  
 
The transformation of drug shops to ADDOs aimed at improving access to patients of 
some essential drugs that were permitted to be sold through prescription only, including 
ALu.  However, most ADDOs are situated in urban and semi-urban areas hence they 
have contributed little to prompt access in rural and remote areas (I). Owners of 
ADDOs are unlikely to operate in rural remote areas where the logistics costs are high 
due to poor transportation networks and sales are low because of a scattered population 
with low purchasing power. Consequently, it is only the ordinary shopkeeper who finds 
it profitable to add antimalarial drugs as one among other profitable commodities being 
sold in the shop 
 
6.1.3 Prompt access to treatment in ordinary shops  
About half of the children who were not taken to government facilities were taken to 
ordinary shops (I) where no subsidised ALu were available. The private sector is 
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reported to be preferred over the government sector due to the user-friendly services 
offered, being closer, faster, offering more convenient opening hours, the availability of 
drugs all the time and the provision of a cheaper source of drugs because they do not 
have to pay formal and informal fees (Amin et al., 2003, Brieger et al., 2001, 
Rutebemberwa et al., 2009b, Williams and Jones, 2004). Although the private sector 
accounts for a large proportion of antimalarials dispensed in Tanzania (Goodman et 
al., 2009), in remote rural villages, it is the ordinary shops, which sell rice and other 
household commodities, that also sell medicine, (Patouillard et al., 2010). Thus most 
studies reporting the advantages of the private sector  base their findings on the formal 
private sectors comprised of registered drug shops which are supposed to be regulated 
through regular inspection and supervision (Hongoro and Kumaranayake, 2000). 
However, the majority of those utilising the private sector in study I, sought care from 
ordinary shops where they received non-recommended drugs. The underlying factors 
for caretakers utilizing ordinary shops was the distance to government facilities and 
ADDOs that were primarily located in semi-urban areas (I) and the relatively high cost 
of drugs charged at FBO facilities (I).  
 
In study II, the level of adherence to ALu treatment was shown to be quite high and 
non-adherence was primarily attributed to untimely administration of the drug, rather 
than taking a fewer number of doses. The Affordable Medicine Facility for malaria 
policy aims to reduce ALu prices to a level equivalent to previous antimalarials (SP and 
CQ), by applying subsidies at the manufacturer level, so that the drugs can be 
affordably accessed through the private sector (Moon et al., 2009, RBM-Partnership, 
2007a). The strategy is likely to improve access to ALu in remote rural areas, even 
through the ordinary shops. However, this might compromise the high level of 
adherence found in study II and elsewhere (Beer et al., 2009, Kabanywanyi et al., 2010) 
because study I showed that a large proportion of caretakers of febrile children in 
remote rural areas sought care from ordinary shops. Although the AMFm strategy 
might  enable caretakers to afford a full course of ACT, drug sellers are reported to sell 
drugs according to patients’ demands and under-dosing is common due to low 
purchasing power (Viberg, 2009), and inadequate knowledge about the importance of 
taking a full course (Hongoro and Kumaranayake, 2000). A study in Asia reported non-
adherence to ACTs due to inadequate doses provided in private facilities (Yeung and 
White, 2005). While these studies were conducted in urban areas, the problems are 
likely to be more manifest in rural areas, where the purchasing power and knowledge is 
relatively lower.  
 
Studies in Kenya reported improvements in the uptake of antimalarials and in the 
behaviour of the members of the community through training of shopkeepers 
(Goodman et al., 2006, Marsh et al., 1999). However, the success observed was on a 
small scale and under the influence of the research team which might not be realized on 
a national scale implementation because the regulatory bodies in many low income 
countries are so weak to even regulate practice in registered drug shops (Goodman et 
al., 2007, Kumaranayake et al., 1997). Unlike previous antimalarials, there is no 
immediate alternative to ACT in the near future. Thus resistance to ACT might be 
catastrophic in an African setting (Trape, 2001, Zucker et al., 2003). Moreover, the 
WHO recommends diagnosis of malaria based on microscopy or RDT. It is not clear 
whether RDT use will be practical when applied by the shopkeeper, and reinforcing 
   49 
safety in blood handling on a nation-wide scale might overstretch the capacity of the 
regulatory bodies to monitor its safety in a community where HIV/AIDS is still a major 
problem.  
 
In the absence of an alternative to ACTs in the near future, strategies to improve 
prompt access, in a setting where a substantial proportion of caretakers seek care from 
ordinary shops, should be accompanied with efforts to preserve drug efficacy the 
existing high level of adherence to treatment (II), in order to avoid the development of 
drug resistance. Resistance to ALu will lead caretakers to seek alternative treatment 
thus reducing prompt access to the recommended drug (ALu), thus creating a potential 
for non-adherence, forming a vicious cycle, spiralled by the lack of an alternative 
effective antimalarial. Measures to contain the emergence of resistance includes 
increasing access to ALu in rural communities where the burden is high, and ensuring 
adherence to a treatment schedule (Marsh, 1999). Through public-private partnerships 
advocated in the national health policy and strategies, the formal private sector should 
be allowed to continue providing services to people who can afford it, mostly in urban 
areas, while government efforts are directed towards rural remote areas. Strong 
government regulations and oversight will still be required to maintain adequate quality 
services provided by the private sector. 
 
6.1.4 Prompt access to treatment by community health workers  
Community drug dispensers were involved in the provision of a pre-referral dose of 
rectal artesunate to children reported to have malaria but unable to take oral medication, 
with success (III, IV). The involvement of CHWs has been reported to be one of the 
practical strategies for improving access to care in rural areas (Haines et al., 2007, 
Onwujekwe et al., 2007, Pagnoni, 2009). CHWs are much closer to caretakers and offer 
services all the time (Haines et al., 2007). Entrusting CHWs with the responsibility to 
diagnose malaria using RDTs, treat uncomplicated malaria with ALu and provide pre-
referral rectal artesunate to children, where the option for parenteral treatment does not 
exist, could be cost-effective and holistic. The WHO, currently advocates the 
integration of malaria treatment with pneumonia and diarrhoea through the integrated 
community case management (iCCM) strategy (WHO, 2010a).  
 
Studies have reported the feasibility of CHWs to perform all these functions  
effectively (Ajayi et al., 2008b, Mubi et al., 2010, Mukanga et al., 2010). Tanzania was 
among the pioneers in African countries where a country-wide Village Health Workers 
Programme was implemented in the 1980s (Heggenhouggen et al., 1987). The main 
lesson from the failed programme was lack of sustainability that led to a high drop out 
rate. Recently, there have been  some success stories in some countries, although the 
implementation scale was small (Haines et al., 2007, Onwujekwe et al., 2007, Pagnoni, 
2009).  
 
While operational research might be required to inform the decision making process 
(Pagnoni, 2009), a number of issues have to be considered prior to the re-introduction 
of CHWs. Integration of CHWs into the health-care system, improvement of  their 
scope of work, incentives, technical support and career development are important 
(Hermann et al., 2009 ). The current Tanzania national health policy recognises the 
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position and role of village health workers as providers of health services at the village 
health post, but it does not provide them with salaries (MoH&SW, 2002). Although the 
Primary Health Care Service Development Programme (MMAM) strategy aims to train 
multipurpose CHWs (MoH&SW, 2007c), there are no suggestions about how they 
should or will be supported, remunerated and integrated as part of the workforce for the 
provision of health services. Although the policy document recommends local 
governments to introduce CHWs where feasible, many of them fail to start. To a large 
extent, local governments depend on central government for the financing of district 
health services, including the salaries and personal emoluments for health workers 
(MoH&SW, 2007a). 
 
6.2 CARETAKERS’ UNDERSTANDING OF INFORMATION GIVEN BY 
PROVIDERS  
In study II, adherence to ALu was found to be quite high compared to studies 
implemented during the chloroquine era; and contrary to fears that rapid cessation of 
symptoms might lead caretakers to discontinue treatment and retain the remaining 
tablets for future use (Hinton et al., 2007). Such high levels of adherence have been 
reported in other community based studies conducted in Kilombero/Ulanga in 
Tanzania, Mainland and in Zanzibar (Beer et al., 2009, Kabanywanyi et al., 2010). The 
underlying factors to the high level of adherence to ALu treatment in the present study 
could partly be due to better understanding, by the majority of caretakers (>90%), of 
the information given by providers on how to administer the drug (Okeke, 2010). The 
pre-packaged pills in packets with pictorial instructions (Agyepong et al., 2002, Ansah 
et al., 2001), that were used in study II, also added to the understanding on drug 
administration by caretakers (Piola et al., 2005). High drug efficacy has also been 
reported to influence adherence to treatment (Chuma et al., 2009, Yeung and White, 
2005).  
 
In addition, caretakers were faced with a dilemma to adhere to referral advice by 
having to weigh the severity of child condition against the magnitude of obstacles in 
accessing care at the health facilities (IV) leading to delay in taking the appropriate 
action. Knowledge regarding the urgency and rationale for adhering to referral advice 
might have tipped the balance in favour of adherence to referral advice. Caretakers who 
understood the rationale for the adherence and its urgency were more likely to 
persevere and overcome the obstacles compared to those with less understanding. 
Likewise, knowledge about the recommended treatment for uncomplicated malaria, 
was found to be in favour of caretakers’ decisions to seek treatment and care from 
government facilities (I).  
 
Contrary to expectations, caretakers’ basic (primary level) education, provided for 7 
years, was not found to influence any of the outcomes studied in this thesis (I-III). 
Hence their understanding of the reasons why their child should be given the full 
treatment for ALu and the reasons for urgent hospital care determined their adherence 
behaviour. Some studies reported that secondary level education influenced adherence 
to a treatment schedule (Beer et al., 2009). In studies I-IV, caretakers reported to having 
secondary level education were too few (<10) to allow analysis. Was the type of 
education offered at this level not adequate to prepare caretakers to seek or become 
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exposed to appropriate information through written media? Further research on this 
might be required. 
 
6.3 POVERTY AS A BARRIER TO ACCESSING CARE AND ADHERING 
TO TREATMENT 
Poverty was one of the underlying factors found to influence almost all the outcome 
variables in this thesis (I-IV). Children whose caretakers were poor were less likely to 
seek care from government facilities (I) and to adhere to an ALu treatment schedule 
(II). Although in study III no statistically significant association was found between 
SES and adherence to referral advice, the cost of services, where charges were levied, 
was found to be a deterrent. This is an indication that poverty, in a way, did influence 
adherence to referral advice. Several studies have reported the influence of SES on 
accessing care for febrile children  (Rutebemberwa et al., 2009a).  Interestingly, in 
study IV, caretakers reported that cost was not a deterrent to adherence to referral 
advice, if the child had severe symptoms or had not improved after the pre-referral dose 
of rectal artesunate. Caretakers from low SES were found to be less likely to own a 
radio and to have knowledge about malaria treatment (I). This puts them at a 
disadvantage in the opportunity to acquire the knowledge necessary for decision 
making, faced with a febrile child. Ownership of radios might also have facilitated 
caretakers’ adherence to administration of ALu doses according to the schedule, 
through following up the timing from radio programmes. 
  
The barriers likely to be met when accessing care from a government facility or 
adhering to referral advice might have an impact on a caretaker, a family and their daily 
survival. Caretakers in study III were drawn from villages that were 5 km away from a 
nearby government facility. Caretakers, therefore, had to walk for 10 km to access care. 
Adding the long waiting time at the facility, this might mean spending half of the day 
seeking care for the child. Since the majority of caretakers in rural areas are poor 
(National-Bureau-of-Statistics, 2002) the opportunity cost to access care might be high, 
thus compelling them to weigh the risk between the child’s condition and the time 
involved in accessing care. Policies stipulating free medical care for children were not 
known by some of the caretakers (IV). Even if they knew, the informal payments 
reported to be solicited by some providers (I, III, IV) might deter them from not 
seeking care from a government facility. Apparently, the national policy and 
international organisations’ strategies aim at not making cost  a barrier to accessing 
malaria interventions (MoH&SW, 2002, Roll-Back-Malaria-Partnership, 2005) and 
reaching the poor in rural remote areas high in the priorities (GFATM, 2010, Jong-
wook, 2003b, MoH&SW, 2002, USAID, 2009). Efforts to reduce the costs and 
reaching children in rural remote areas need to consider strategies to contain such 
informal payments.  
 
6.4 METHODOLOGICAL CONSIDERATION 
Design -Selection bias favouring the poorer –Studies were conducted in rural villages 
(1) and rural villages that were more than 5 km from a nearby health facility (III). This 
was purposely done in order to identify barriers in places where the burden of malaria 
is the highest. However, this excluded children from semi-urban and urban areas where 
people are less poor. The focus on the poorest increased homogeneity of the study 
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population and thus reduced the likelihood of detecting a difference if it existed in 
behaviour between rural and urban households or in different income classes in the 
rural areas.  
 
Study power - In the design of studies I and III stratified sampling was conducted in 
order to capture diversity in geographical location and type of action taken in the 
respective studies. However, in the calculation of sample size we did not consider 
analysis within the stratum. This might have compromised the power of the studies (I, 
III) to detect a difference within stratum, if it existed.  
 
Study generalization – Random selection was performed in all studies (I-IV) to ensure 
generalization of the study findings. However, Study II enrolled children who attended 
health facilities thus reducing the probability of recruiting those not utilizing care from 
health facilities. Since the study aimed at determining adherence to ALu and the drug 
was available only in health facilities, generalization to the whole population was not 
intended. 
 
Loss to follow up – In Study III, loss to follow up was higher among those who went to 
traditional healers. This reduced the ability of the study to analyse data using this 
population group. 
 
Self reporting and recall- Self reporting has the advantage of obtaining responses in a 
direct and versatile way (Denzil and Lincoln, 2000). However, it has the disadvantage 
of being subjective and demonstrates problems concerned with recall (Nwanyanwu et 
al., 1996, Roberts et al., 1996) especially for topics that are sensitive and stretch over  a 
long period. The issue of accessing care and administration of drugs are less sensitive. 
The outcome variable in study I, and to some extent study II, was determined through 
caretakers’ report. The accuracy of measurements in these studies therefore depended 
on the ability of the caretaker to recall events. In studies I and II the questionnaire was 
administered within an average period of one week in order to minimise the recall 
period to enable the collection of detailed data. It has however been argued that two 
weeks is optimal because it balances between extracting unnecessary detail and 
forgetting the necessary detail (Freij et al., 1977). The fact that less than 10% of the 
febrile children in study I were taken for care outside home shows that they were 
serious enough to require attention. In study II details about how drugs were 
administered was needed and this required a shorter recall period than two weeks 
(Roberts et al., 1996). When interviewing caretakers there is usually an urge on their 
side to provide socially desirable responses. We tried to minimize this by making clear 
to the caretakers the objectives of the studies prior to the interviews. Recalling detailed 
information about how the drug was administered after seven days, might result in data 
inaccuracy as some details might be forgotten. While in study I and II caretakers were 
asked to recall events that occurred in the past seven days, in study III the ranges were 
wider, that is, between 3 months and three years. The amount of detail required was 
more in study II where caretakers were expected to recall information on food intake 
between one to six days prior to interview. However, caretakers are reported to pay 
more attention to a sick child than other members of the household, this might have 
improved the recall of events. Recall was minimized in study III by using some of the 
data collected during the disease episode such as symptoms and action taken; and 
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adherence to referral advice verified using facility records. The fact that rectal 
administration of modern medicine is a rare event in the community might also have 
contributed to better recall by caretakers. 
 
Use of community health workers in data collection 
 
CHWs were used in data collection in study I. Since the majority had 7 years basic 
education, this might have compromised data accuracy. This limitation was 
compensated by training them for one-week followed by another week of pilot study. 
The weekly meeting with supervisors were also utilised to discuss and improve data 
quality. 
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7 CONCLUSIONS AND RECOMMENDATIONS 
7.1 CONCLUSIONS  
• Despite the high level of international and national level commitment and large 
funding coupled with pro-poor policies and strategies, prompt access to 
artemisinin-based combination therapy (ACTs) was quite low in rural remote 
areas where the burden is highest (I). Seeking care from a government facility 
was the overwhelming factor in accessing ALu promptly. Lack of prompt 
access was mainly attributed to receiving non-recommended drugs. 
 
• The contribution of formal private facilities that had subsidized ALu was low 
because they were not easily reached by caretakers due to the relatively high 
cost of drugs at FBO facilities and most ADDOs were located in semi-urban 
areas (I).  
 
• Since the majority of caretakers who sought care from the private sector went to 
ordinary shops, efforts to improve the low prompt access (I) should be made 
with caution, lest the high levels of adherence, hitherto attained (II), are 
compromised. 
 
• Caretakers of children with altered consciousness and or convulsions and 
children who had not improved after pre-referral dose of rectal artesunate were 
more likely to adhere to referral advice (III), and less likely to go to traditional 
healers. Better caretakers’ understanding about urgency and rationale for 
referral advice helped to overcome obstacles in accessing care from government 
facilities (I, III, IV). 
 
7.2 RECOMMENDATIONS AND POLICY IMPLICATIONS 
There is a need to prioritize, realign and reinforce implementation of pro-poor policies 
such as waiver for under fives, and improve access to government facilities to remote 
rural areas, in line with integrated Community Case Management (iCCM). Improving 
prompt access to ALu should be the first priority in the control of malaria because in 
addition to curing uncomplicated malaria this strategy reduces the number of cases of 
severe malaria. Most of the potential providers have several inadequacies in improving 
access to ALu in rural settings, including government facilities. However, the 
government, as the duty bearers for the health of the people, needs to strengthen its 
services to reach remote rural areas. The Government should also consider meeting 
operational costs for FBO facilities, especially, those located in areas where no 
government facility is accessible.  
 
The government strategy to reach remote rural areas through MMAM strategy that 
aims at having a dispensary in each village is unlikely to be accomplished before 2017, 
given the severe shortage in the health workforce. Yet, the RBM Partnership malaria 
control goals of universal coverage with ACTs and reducing malaria mortality to near 
zero, have to be attained by 2015. Mainstreaming CHWs as a cadre in the health system 
will not only be a temporary solution to reaching rural communities, but will also serve 
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as a long term solution to linking the formal health care services with the community, 
thus fostering community participation in preventive services, which was the primary 
goal of introducing CHWs. Reintroduction of CHWs should be preceded with an 
outlining mechanism for their career path, technical support and remuneration, which 
have been the major problem in their sustenance. Their scope of work should be 
matched to that of integrated Community Case Management (iCCM) where CHW are 
trained to treat three major killer diseases that is malaria, pneumonia and diarrhoea. 
 
Given that ordinary shops are second to government facilities as a major source of 
drugs in remote rural areas, efforts to increase prompt access to ALu in these settings 
should be matched with efforts to curb indiscriminate distribution and dispensing of the 
drug. This is on the understanding that once resistance sets in, it will compromise 
prompt access thus forming a vicious cycle. Regulatory bodies should be supported to 
improve capacity to reach drug outlets in the whole country and should also be 
challenged by the government to apply sanctions where regulations are breached, 
through a checks-and-balance system.  
 
While there is need to urgently introduce rectal artesunate as a strategy to reduce 
malaria mortality, the challenge will be to deal with some caretakers whose children 
had less severe symptoms prior to or improved after pre-referral treatment. Since no 
further care was sought by caretakers once the child improved, this might indicate that 
the fever was self limiting, perhaps of viral origin. Nevertheless, there will still be a 
need to address the misunderstanding and misconceptions on the reasons for referral 
and its urgency through a strong and sustained communication strategy to ensure 
peoples’ understanding on the rationale for referral.  
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